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ABSTRACT OF THESIS 
 
 
 
 
INFLUENCES OF SUPPLEMENTING A MANNAN OLIGOSACCHARIDE 
CONTAINING PRODUCT TO PIG DIETS ON SOW AND WEANLING PIG 
PERFORMANCE  
 
 The objective of these studies was to evaluate the effect of supplying mannan 
oligosaccharides (MOS) to pig diets on both weanling pig and sow performances.  
 Nursery pigs challenged with LPS to stimulate an immune challenge had 
increased body temperature and respiratory rate as well as elevated serum cortisol and 
TNF-α concentration, MOS-supplemented pigs had a lower rectal temperature and 
respiratory rate which implied that MOS improves some aspect of the immune 
function of piglets. 
MOS supplementation in sow diets during late gestation and lactation had no 
effect on litter size, but the piglets from MOS-fed sows were heavier at birth (P = 
0.04), at weaning (P = 0.03), and during the entire nursery period (P < 0.01). 
Moreover, milk fat and protein levels as well as the Ig concentrations in milk from 
MOS-fed sows were numerically higher (2 – 12%; P > 0.10) than control sows. 
 Overall, MOS supplementation in the nursery diet may have limited effects on 
the growth performance, but may have some beneficial influence on pigs under 
immune challenge. Furthermore, including MOS to the sow diet during late gestation 
and lactation can potentially improve piglet body weight as well as growth during the 
suckling and nursery periods. 
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Chapter 1. Introduction 
Mannan oligosaccharides (MOS) are complex sugars which consist mainly of 
mannose that are found mostly in the cell walls of yeast and plants. MOS was first 
introduced as a feed additive in 1993 (Hooge, 2003). It has been suggested that 
dietary MOS has benefits in improving gut health by reducing pathogen colonization 
(Newman, 1994; Castillo et al., 2008).  
Most enterobacteria have a specific organelle, type 1 fimbria, which mediates 
binding to mannose on the intestinal wall (Firon et al., 1983). After they adhere, the 
pathogens colonize and proliferate in the intestine, which consequently causes 
disease. When dietary MOS is presented, pathogens which normally adhere to 
mannans on the mucosal surface of the intestine may instead bind to the mannan 
component of products. After this, pathogens are flushed from the intestinal tract 
rather than colonize in the intestine (Newman, 1994). 
There are many studies showing that adding MOS to the diet has improved the 
growth performance of broiler chickens (reviewed by Hooge, 2004a), turkeys 
(reviewed by Hooge, 2004b), calves (reviewed by Hooge, 2006) and pigs (reviewed 
by Pettigrew, 2000). There are also other studies demonstrating that dietary MOS aids 
the immune system and gut health of broiler chickens (Spring et al., 2000), turkeys 
(Savage et al., 1996), calves (Franklin et al. 2005), and rabbits (Mourão et al., 2006). 
In swine, the immune system is not fully developed at birth, and thus it is 
important to improve the neonatal piglets’ immunity through sow’s milk and the 
cleanliness of the environment. Studies have shown that adding MOS to sow’s diet 
increases piglet weight at birth and weaning, improves pre-weaning growth, and 
raises survival rate (Pettigrew et al. 2005). Also, Spring and Geliot (2003) observed 
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that, adding MOS to the gestation diet 8 weeks prior to farrowing reduced the number 
of coliforms and Clostridium perfringens in the feces of the sow during farrowing.  
Therefore, the objective of the current research was to evaluate the effect of 
supplying mannan oligosaccharide to nursery pig on growth performance and immune 
challenge (Chapter 3) and to gestating and lactating sow on reproductive performance 
and milk quality in conjunction with continuing pigs born to these sows on a MOS 
study in the nursery (Chapter 4). 
  
2 
Chapter 2. Literature review 
2.1 Health and nutrition  
2.1.1 Sow nutrition 
The productive efficiency of a sow is the most important biological key to 
economic profitability of a pig farm apart from a disease outbreak. Sows with low 
productive efficiency are characterized by smaller litters, weaker piglets, or longer 
period of postweaning anestrus. Although the productive efficiency is influenced by 
improved genotype, management, and facilities, nutrition is a primary factor to obtain 
the maximum potential of the sow. Feeding strategy during pregnancy is important 
because it determines the size and subsequent viability of piglets at birth, the amount 
of mammary tissue the sow contains at parturition, and as well the potential milk 
production of the sow during lactation (Pluske et al., 1995). 
There are many nutrients that affect sows’ performance, including energy, 
protein, minerals, and vitamins.  Energy and protein are the factors that are directly 
used for growth and maintenance. This literature review mainly focuses, therefore, on 
the energy and protein/amino acids requirements for the sows.  
Energy for sow diets is used for maintaining normal body functions, growth of 
fetal, placental, uterine, and mammary tissues, and deposition in maternal body 
tissues. Maintenance of the sow and the growth of the embryo are considered to 
receive first priority for the nutrients. Once those priority needs are satisfied, the extra 
nutrients are deposited in maternal tissues (Trottier and Johnston, 2001). However, if 
there are any insufficient dietary nutrients for the priority needs, those nutrients will 
be withdrawn from the sow’s body tissue, and thus may subsequently cause 
reproductive failure.  Johnston et al. (1989) and Trottier and Johnston (2001) stated 
that reduced weight gain during gestation due to insufficient energy intake may still 
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allow successful lactation, but results in thinner sows at weaning and delayed 
postweaning estrus. 
The feed and energy requirements of the pregnant sow will vary with her body 
weight, target body weight gain during pregnancy, and other management and 
environmental parameters. NRC (1998) suggested the daily maintenance energy 
requirement as 106 kcal ME/kg metabolic body size (BW0.75). At the early period of 
gestation, the nutrients in the diet should be sufficient not only for the maintenance 
and growth of the sow, but also for the conception, and for the developing 
embryo/fetus. NRC (1998) also recommends that the daily energy requirement for 
protein accretion is 10.6 kcal of ME/g; for fat accretion is 12.5 kcal of ME/g; for the 
growth of the fetus is 35.8 kcal of ME per pig in the litter.  
This program for calculating the energy requirement for gestating sows is easy 
to apply. However, this single-phase feeding strategy may not be appropriate to 
support the nutrient needs of pregnant sows since their weight gain and fetus growth 
changes during gestation (Ji et al., 2005; McPherson et al., 2004), being an 
accelerated rate in late gestation. Ji et al. (2005) suggested that an optimal feeding 
strategy, i.e., 2-phase feeding, for pregnant sows should be sufficiently flexible to 
adjust for the nutrient allowance of gilts according to their nutrient needs for both 
maternal and fetal growth.  
Although increased sow feed intake during gestation increases the growth of 
the fetus and deposition of body fat and protein, it may cause reduced energy intake 
and increased weight loss during lactation (Cooper et al., 2001). Therefore, it is 
desirable to limit energy intake during pregnancy to control weight gain (NRC, 1998). 
However, fetal growth increases dramatically in late gestation with 60% of growth 
occurring during the last 30 days of gestation (Pluske et al., 1995), which 
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demonstrates that it is necessary to increase feed intake during this period to 
accommodate the increased nutrients required for rapid fetus growth.  
During late gestation (d 50 to 110), the ME requirement for sows is increased 
from 3 to 12% of total maternal energy intake. This period is also the occurrence of 
the acceleration in fetal weight (Pluske et al., 1995). In addition, milk production is a 
gradually accumulated process in mammary glands during gestation.  Since the 
colostrum and milk are the main sources of energy and passive immunity for the 
neonatal pigs, the quantity and the quality of colostrum and milk are extremely 
important for having healthy piglets.  
After parturition, sow feed intake is even more important than it is during 
gestation. This is because the feed intake directly affects the growth and development 
of the neonatal piglets via the milk produced and influences the reproductive 
efficiency of the sow in the next parity. Sows with sufficient nutrient intake influence 
the nutrient composition in the milk that subsequently affects the piglets’ growth and 
health (Trottier and Johnston, 2001). On the other hand, insufficient nutrient intake 
will compromise the sow’s body composition, hence it takes time for the sow to 
recover and return to service. Koketsu et al. (1996a) has shown that sows with either 
low feed intake throughout lactation or low feed intake at various times during 
lactation are more likely to have lower litter size at weaning and a longer period 
before the next estrus.  
The daily energy needs during lactation include a requirement for maintenance 
of the sow and for milk production. The energy requirement for milk production can 
be estimated from the growth rate of the suckling pig and the number of pigs in the 
litter. The equation of estimated milk gross energy (GE) is derived from Noblet and 
Etienne (1989) where GE per day = (4.92 × ADG × number of pigs) - (90 × number 
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of pigs). This amount is then converted to dietary energy where dietary ME = (6.83 × 
ADG × number of pigs) - (125 × number of pigs) (NRC, 1998).  
Among the essential amino acids, lysine is considered to be the first limiting 
amino acid for establishing the ideal protein for both gestation and lactation. The daily 
requirement for lysine is the sum of the requirements for maintenance and for milk 
production, with a reduction to account for the use of the sow’s body protein to 
provide part of the lysine needed for milk production. The daily maintenance 
requirement for true ileal digestible lysine during gestation and lactation is considered 
to be 36 mg/kg BW0.75; the requirement for milk production is suggested to be 22 g of 
apparent ileal digestible lysine/kg of litter weight gain (NRC, 1998).  
Many studies found that the survival rate of a heavier piglet at birth is higher 
than that of a lighter piglet (Smith et al., 2007; Tokach et al., 1992; Hall et al., 1987). 
The heavier piglet at birth is also heavier at weaning (Smith et al., 2007; Tokach et al., 
1992). Furthermore, it has been studied that the weaning weight of a pig affects its 
growth rate during the growth-finishing period and its carcass characteristic (Gondret 
et al., 2005; Gondret et al., 2006; Wolter and Ellis, 2001). Similarly, a young, fast 
growing pig will also tend to be a healthy piglet because its immune system is 
promoted by rapid growth (Gadd, 2003). The good immune status reduces the 
possibility of being attacked by the pathogens and subsequently helps this fast 
growing piglet to be a fast growing nursery, and then finisher pig.  
Having heavier and healthier piglets costs the producer less money to feed and 
house as the pigs reach market weight earlier than lighter pigs. It also increases the 
profit from larger litter size and lower mortality of the piglets. Therefore, the nutrition 
for pregnant sows becomes an important issue for the swine nutritionist.  
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2.1.2 Neonatal piglet nutrition 
Major body constituents which potentially are used as energy-yielding 
substrates for new born piglets are protein, glycogen, and fats (Le Dividich et al., 
2005). At birth, neonatal piglets have really low energy reserves in the body, 
including 1-2% fat, 8-25% liver glycogen, and approximately 12% protein (Pluske et 
al., 1995; Le Dividich et al., 1991; Elliot and Lodge, 1977). However, due to the 
dramatically and rapidly depleted glycogen reserve within 12 hours post-partum 
(Elliot and Lodge, 1997), a varying low rate of protein catabolism and a low amount 
of body fat content, colostrum becomes the major energy source for neonatal piglets.  
Many digestive enzymes are present at birth (Figure 2.1). The major energy 
source for neonates in colostrum is fat and lactose. According to the research of Le 
Dividich et al. (1994), 59% of fat and 100% of lactose are digested. Lactose 
concentration in the colostrum is 3.4%, while its concentration in milk is 5.3% 
(Darragh and Moughan, 1998; Klobasa et al., 1987; Trottier and Johnston, 2001). 
Hydrolyzed lactose yields glucose and galactose which are readily absorbed into the 
piglet’s blood and are either metabolized directly, or used to be stored in the liver and 
muscle as glycogen (Darragh and Monghan, 1998). Veum and Odle (2001) 
summarized that lactase activities are high at birth, reaching a maximum at 1 week 
before declining to 6 or 8 weeks of age; maltase activity is low in intestinal mucosa at 
birth, but increases gradually from birth to 6 or 8 weeks of age; also sucrase activity is 
not found at birth, but is present by 1 week of age. 
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Figure 2.1. A composite illustration of digestive enzymes development (developed 
from Manners et al., 1972; Veum and Odle, 2001; and Lindemann et al., 1986) 
 
The fat content in sow colostrum and milk are 5.9% and 7.9%, respectively 
(Darragh and Moughan, 1998; Klobasa et al., 1987; Trottier and Johnston, 2001). 
Pancreatic lipase activities are high at birth, drop transiently with the onset of suckling 
and weaning, and then increase with age (Lindemann et al., 1986; Veum and Odle, 
2001). The high level of lipase and lactase helps neonates digest fat and lactose in 
colostrum faster, thereby helping them to utilize the energy for growth, activity, and 
heat production.  
The quantity and quality of colostrum is influenced by sow genotype, parity, 
endocrine status, nutrition, environment, litter characteristics, or a combination of 
these factors (Farmer and Quesnel, 2009). On average, the content of fat, protein, and 
lactose in colostrum is 5.9%, 15.1%, and 3.4%, respectively; the content of fat, 
protein, and lactose in milk is 7.6%, 5.5%, and 5.3%, respectively (Darragh and 
Moughan, 1998; Klobasa et al., 1987; Trottier and Johnston, 2001). 
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Table 2.1 Protein content in colostrum and in milk (adapted from Darragh 
and Moughan, 1998). 
 Colostrum1 Milk2 
Total Protein, g/100g milk 15.14 5.47 
Casein, g/100g milk 1.48 2.74 
Whey Protein, g/100g milk 14.75 2.22 
IgG, mg/mL milk3 95.6 0.9 
IgA, mg/mL milk3 21.2 5.3 
IgM, mg/mL milk3 9.1 1.4 
1 Taken immediately postpartum 
2 Classified as milk samples collected between 14 and 21 days postpartum. 
3 The total Ig in colostrum is 125 mg/mL which is equivalent to 12.5 g/100mL 
 
Proteins are the predominant components of total solids in the colostrum 
(Table 2.1). There are 2 groups of proteins in colostrum and milk, including caseins 
and whey proteins. Casein is the main source of dietary essential amino acids; it also 
works as the carrier of calcium which helps the absorption of calcium. The study from 
Le Dividich et al. (1994) showed that colostral energy and nitrogen are very 
efficiently utilized by the neonates, where the efficiency of ME utilization for protein 
and fat synthesis and of glycogen degradation is approximately 0.91. Conversely, 
whey proteins include blood serum albumin, α-lactoalbumin, β-lactoglobulin, 
Immunoglobulin G (IgG), Immunoglobulin A (IgA), Immunoglobulin M (IgM), 
lactoferrin, and other minor proteins. 
Colostrum has a high concentration of total solids and protein but only low 
levels of fat and lactose. At the same time, the low proteolytic activity in the 
gastrointestinal tract of the neonatal piglets as well as the protease inhibitor in the 
colostrum allows the newborn piglet to ingest colostral contents (Pluske et al., 1995; 
Le Dividich et al., 2005). The majority of proteins in colostrum are whey proteins 
(14.75% of total colostrum; Darragh and Monghan, 1998), but the percentage of 
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protein dramatically decreases within 24 hours post partum (Klobasa et al., 1987). In 
milk, the proportion of casein and whey proteins to milk are similar (2.74 % and 2.22 
%, respectively; Darragh and Monghan, 1998).  
Placental transfer of immune antibodies is almost nil in the pig (Pond, 1973). 
Although most components of the immune system of the piglet are present at birth, it 
takes several weeks of life to become functionally developed. Thus, maternal 
immunoglobulin needs to be provided for passive immune protection until the piglets 
are able to synthesize adequate amounts of antibodies (Le Dividich et al., 2005). Due 
to the low activities of the gastric and pancreatic proteolytic enzymes in neonatal pigs 
at birth and protease inhibitors in colostrum, piglets can absorb intact immunoglobulin 
directly into their blood stream (Le Dividich et al., 2005).  
IgG is the predominant immunoglobulin in the colostrum (76% of total 
immunoglobulin), but its concentration in milk rapidly declines during the first 24 
hours after parturition (approximately 85% of reduction; Klobasa et al., 1987). The 
concentration of IgA and IgM also declines with time, but the reduction is not as 
pronounced as in IgG. Thus, IgA becomes the dominant immunoglobulin in mature 
milk. Darragh and Moughan (1998) stated that the shift of the immunoglobulin level 
reflects the changing needs of the piglet, as absorption of whole protein gives way to 
the maintenance of localized immune protection within the gut.  
In addition to the immunoglobulin, there are some other cells in colostrum and 
milk that help provide protection against infection in mammary glands and piglets’ 
gastrointestinal tract, including neutrophils, lymphocytes, macrophages, and epithelial 
cells (Darragh and Monghan, 1998). Leukocytes in colostrum are absorbed 
intracellular in the upper small intestine, enter the lymphatic vessels, and are 
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transported to the mesenteric lymph nodes, which then stimulate the development of 
cellular immunity of the neonates (Blecha, 1998). 
The energy and immunoglobulin in colostrum not only helps piglet growth 
and defense against disease, but also aids the development of the gastrointestinal tract 
and regulation of blood glucose of piglets (Devillers et al., 2004).  Colostrum and 
milk contain high levels of growth factors that accelerate proliferation and maturation 
of the gut in neonatal animals (Kelly and King, 2001).  
 
2.1.3 Weaning piglet nutrition 
Piglets are usually weaned between 16 and 18 weeks of age in the 
semi-natural environment (Jensen and Recén, 1989). However, in a practical farm 
system, piglets are weaned between the age of 2 to 6 weeks which is prior to their 
digestive and immune systems being fully developed (Bailey et al., 2005). Regardless 
of the age of weaning, the various stressors, including physical stress (i.e. separation 
from dam, movement to new environment, regrouping with new pen mates, and 
building new social orders) and nutritional stress (i.e. feed type changing from liquid 
sow milk to solid feed), cause the reduction of growth performance and 
immunocompetence during this period (Blecha and Kelley, 1981).  
A high weaning weight usually implies rapid and healthy growth after 
weaning and all the way through to slaughter (Wolter and Ellis, 2001). The 
post-weaning challenges cause the deterioration of health and growth which increases 
costs in the industry, including a longer feeding period before reaching market weight, 
less turnover rate of the facility, and possible requirements for specific nutrient 
supplements for weaker pigs. Therefore, the most important mission for the 
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nutritionist to deal with the post-weaning growth check is to reduce the stress during 
weaning transition and, thereby, to improve growth and immunity. 
The nutrients used as energy sources in animal feed are carbohydrates and fats. 
According to NRC (1998), the energy level in the diet for pigs weighing 3 to 20 kg 
should exceed 3265 kcal/kg of metabolizable energy (ME). McNutt and Ewan (1984) 
estimate that the ME requirement for maintenance for the 4-week-old weaned pig is 
115 kcal/day/kg0.75. However, feed intake is usually low in the first days after 
weaning due to the unfamiliarity of the pig to the feed type and other stresses. This 
indicates that the energy intake is not sufficient. A high energy-content-diet may 
increase energy intake only if the right energy source is chosen. Fat utilization is 
inefficient at weaning because of the low lipase activity during this period 
(Lindemann et al., 1986; Maxwell and Carter, 2001). The energy sources for optimal 
utilization in newly weaned pigs are lactose, glucose, or sucrose, in dried whey or 
dried skim milk (Maxwell and Carter, 2001; Owsley et al., 1986).  
Proteins are complex components that form from various combinations of 
amino acids and/or other compounds, i.e. carbohydrates or lipids. Amino acids are the 
basic structure for body tissues, including muscles, skin, connective tissue, nerves, 
and organs. Amino acids are classified by their essentiality to the dietary protein 
requirement. The non-essential amino acids are those that can be synthesized by the 
animal itself while the essential amino acids have to be provided in the diet. To attain 
optimal growth, the dietary amino acid content must be balanced. 
Lysine has been considered the limiting amino acid in the porcine diet. Many 
studies indicate that pigs which are fed higher lysine levels than that recommended by 
NRC (1998) have a higher growth rate and improved feed efficiency (Maxwell and 
Carter, 2001). Under the concept of ideal protein, suggested by Fuller and Wang 
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(1990), Chung and Baker (1992), and Cole and Van Lunen (1994), the amino acid 
requirements are presented as a ratio to lysine.  
Vitamins and minerals are also important for growth of tissue and maintaining 
or aiding the regulation of the body. Ca and P are the major components of the 
skeleton while vitamin D is involved in the regulation of Ca and P absorption and 
accumulation in bones. Ca is quite low in cereal grains and most plant protein 
ingredients, thus most Ca is supplied by inorganic sources. In contrast to Ca, most 
cereal grains and most plant protein ingredients contain sufficient levels of P, but it is 
stored as a phytic phosphate which is almost indigestible by pigs. Moreover, phytate 
has the potential to form insoluble salts with Ca, Fe, Zn, Mn, and Cu (Shelton et al., 
2004), which may decrease the availability of these minerals. Therefore, the needs of 
P and these minerals have to be added in an inorganic source in the same way as Ca. 
The alternative method is adding phytase into the diet. Phytase hydrolize the 
undigestible phytate and thus releases the phytic P, which increases the phosphorus 
bioavailability (Yi et al., 1996).  
Most vitamins and minerals regulate the bodily functions as cofactors of 
enzymes as well as directly influencing the tissue. For instance, Cu is a component of 
amine oxidase that inactivates and catabolizes active biogenic amines (Linder, 1991). 
Enzymes that contain Zn protect the membrane integrity against peroxidative damage 
(Hill and Spears, 2001). Coffey et al. (1994) and Hill et al. (2000) showed that high 
dietary levels of Cu and/or Zn improved growth performance of weaning pigs which 
may be through effects on the microbial population of the gastrointestinal tract.  
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2.1.4 Gut health 
During suckling, there are some growth factors in milk, such as epidermal 
growth factor (EGF) and insulin-like growth factor-1 (IGF-1), which contribute to 
neonatal gastrointestinal development (Blecha, 1998; Odle et al., 1996). It has been 
found that EGF and IGF-1 stimulate the activity of the digestive enzymes in the 
neonatal piglet’s intestine and increase villus length (reviewed by Odle et al., 1996). 
Kingsnorth et al. (1990; cited by Odle et al., 1996) suggest that supply EGF to 20-kg 
pig diet may aid in the recovery of traumatized gastric and intestinal tissues.  
Nevertheless, the removal of these growth factors from milk and the stress 
during weaning causes the change of the intestine morphology. Villous atrophy and 
crypt hyperplasia were believed to be a result of stress, but there is evidence that it is 
more closely related to the reduction of feed intake over the weaning transition (Kelly 
and King, 2001, Spreeuwenberg et al., 2001). Yet the low feed intake is also an effect 
caused by stress. It was observed that some newly weaned pigs may take 3 minutes to 
consume their first meal, but still some others may take even longer (up to 56 hours) 
to discover the food (Brooks et al., 2001). The morphological change as well as the 
decreased digestive enzyme activity influence the digestive and absorptive capacity 
and may lead to malabsorption, dehydration, enteric infection, and diarrhea.  
Improving feed intake during the immediate post-weaning period is very 
important for the development of the small intestine and subsequent growth 
performance (Pluske et al., 1995; McCracken et al., 1999). There are marked changes 
to the structure and function of the small intestine that happen within 24 hours of 
weaning, and generally comprise a decrease in villous height and an increase in crypt 
depth as well as reductions in the specific activity of the digestive enzymes, such as 
lactase and sucrase and a reduced absorptive capacity (Pluske et al., 1995). Epithelial 
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cells need energy to maintain gut integrity. Glutamine is considered as the fuel for 
enterocytes and provides amine group to support their metabolism as well as the 
structure and the function of the small intestine (Pluske et al., 1997). The effect of 
post-weaning low feed intake on small-intestinal architecture might be ameliorated by 
providing adequate energy for the epithelial cells (Vente-Spreeuwenberg et al., 2003).  
In addition to stress and low feed intake, the enterobacteria population may 
also contribute to the growth reduction and disease during weaning. The intestine of a 
newborn animal is considered germ-free (Maxwell and Stewart, 1995). However, 
soon after the neonates are born and consume their first meal, the intestine will be 
colonized by the gut bacteria which are from the birth canal, teat, sow feces, and the 
environment. These pathogens are controlled by maternal IgA (Kelly and King, 2001). 
However, after weaning, these pathogens use the undigested chyme and sloughed 
intestinal cells as their energy source to colonize and proliferate (Pluske et al., 1997).  
Kelly (2004) stated that the most important step to establish enterobacterial 
infection is the attachment for pathogen to host tissue. The attached bacteria regulate 
the gene program in intestinal epithelial cells and thus influence the expression of 
epithelial cell products that subsequently alter the physiological and biochemical 
functions of intestinal barriers (Kelly, 2004). There are many studies interested in 
improving weaning pig’s intestinal morphology, digestive enzyme activity, and 
intestinal bacteria population. Most studies concentrate on probiotics (e.g., 
lactobacillus, bifidobacteria, yeast, etc.) and/or prebiotics (organic acids, 
oligosaccharides, etc.) in the piglet’s diet. 
Lactic acid bacteria (LAB), such as lactobacilli and bifidobacteria, compete 
within the binding sites in the intestine and thus reduce the colonization of the 
pathogens, e.g., E. Coli and Salmonella. In addition, LAB produces lactate which 
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reduces the intestinal pH and consequently suppresses the growth of the pathogens. 
Pollmann et al. (1980) showed that adding a microbial feed additive (lactic 
acid-producing bacteria) with an antibiotic (virginiamycin) to a weaning pig’s diet 
improves the average daily gain and feed/gain ratio. Similarly, Huang et al. (2004) 
indicated that lactobacilli supplementation in the drinking water of weaning pigs 
decreased E. coli and aerobe counts (P < 0.01) but increased Lactobacilli and 
anaerobe counts (P < 0.01) in digesta and mucosa of most sections of the GI tract.  
Organic acids reduce gastric pH, which subsequently influences the activities 
of the digestive enzymes. Because of this acidic environment, the intestinal microflora 
activities are suppressed and thus reduce the incidence of diarrhea. It has been 
observed that supplying organic acid, such as citric, fumaric, and lactic acid, 
significantly improved the growth performance and feed efficiency of weaning pigs 
(Falkowski and Aherne, 1984; Burnell et al., 1988; Radcliffe et al., 1998). 
Furthermore, Tsiloyiannis et al. (2001) indicated that organic acid supplementation 
reduce incidents of diarrhea, thus increasing grow performance. 
Yeast contains enzymes, vitamins, and other nutrients or growth factors that 
have been said to produce beneficial production responses in pigs (Kornegay et al., 
1995). Yeast also changes the microflora population in the gut, due to its cell wall 
components (mannans) or directly due to the effect of the competition for the binding 
site on the intestinal wall with the pathogens, which reduces pathogens and toxic 
metabolites and subsequently improves animal health and growth performance (van 
Heugten et al., 2003a). Mathew et al. (1998) concluded that the addition of yeast 
culture to the diets improved feed intake and may have potential benefits of reducing 
the E. Coli count in the gastrointestinal tract. However, the results among experiments 
are not consistent.  
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The optimal nutrition is important to have healthy pigs which consequently 
increase the profit of the pig producer. Healthy pigs need fewer days to reach market 
weight and have the potential to yield more lean muscle. However, balanced nutrient 
supply is not enough. Improving immunocompetence of the pigs provides additive 
effects for pig’s health. 
 
2.2 Immunocompetence  
2.2.1 Immune system 
The immune system is a natural defense of a creature that self-protects the 
body. There are 2 types of immunity, innate immunity and adaptive immunity. Innate 
immunity is the first line of defense against common microorganisms. It is also called 
non-specific immunity that involves phagocytes (macrophages, neutrophil, and 
granulocytes), natural killer cells, and the complement system. Once pathogens 
perforate the epithelial barriers, macrophages and other leukocytes recognize the 
pathogens through the receptors on the surface which triggers the engulfment of the 
bacteria and stimulate the release of cytokines and chemokines. Cytokines affect the 
behavior of other cells which have the receptors for cytokines, whereas chemokine 
attract and activate cells with specific chemokine receptors such as macrophages and 
neutrophil (Janeway et al., 2005).  
In contrast, adaptive immunity, which is activated by the innate immunity, 
consists of lymphocytes which are stimulated by foreign microorganisms’ antigens or 
their product, thus releasing antibodies to protect the body. Adaptive immunity 
provides the ability to recognize and remember the specific pathogen thus responding 
faster when exposed to that pathogen again. Adaptive immune response comprises 2 
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types: humoral and cell-mediated immunity. Humoral immunity is mediated by the 
antibodies that are produced by B-lymphocytes (B-cells) while cell-mediated 
immunity is modulated by T-lymphocytes (T-cells) and their released cytokines as 
well as macrophage and natural-killer cells. The antigen-recognition molecules of 
B-cells are the immunoglobulins; each B-cell produces its specific immunoglobulins. 
In contrast, T-cells do not recognize and bind antigen directly. The specific membrane 
glycoprotein, called major histocompatibility complex (MHC), display peptide 
antigen to T-cells, thus activates T-cells (Janeway et al., 2005). 
T cells are divided into 2 subsets, including cytotoxic T cell (TC cell) and 
helper T cell (TH cell).  Cytotoxic T cell expresses the glycoprotein called CD8 
which recognizes the class Ι MHC molecules of the antigen and thus releases 
cytotoxins to kill the infected cell. In contrast, the TH cell expresses CD4 that 
recognizes class ΙΙ MHC molecules. TH cells include 2 subtypes; Type 1 TH cell 
activates macrophage activity while type 2 TH1 cell stimulates B cell to produce 
antibodies. The functions of each leukocyte are listed in Table 2.2.  
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Table 2.2 Functions of leukocytes that are involved in immunity (Johnson et al., 
2001). 
Leukocyte Primary function 
 Innate immunity 
Neutrophil Phagocytosis and destruction of bacteria 
Produce inflammatory response mediators 
Macrophage Phagocytosis and destruction of bacteria 
Produce inflammatory cytokines that activate other leukocytes 
and that initiate other components of the acute-phase 
response 
Antigen presentation 
Natural killer cell Provide early defense against viruses and certain intracellular 
pathogens 
 Adaptive immunity 
B lymphocyte Produce antibody 
Antigen presentation 
T lymphocyte Combat intracellular pathogens by activating macrophages 
(inflammatory CD4 T cells, TH1) 
Combat extracellular pathogens by stimulating B cells to 
produce antibody (helper CD4 T cell, TH2) 
Destroy infected cells (CD8 cytotoxic T cells) 
 
 
Clonal selection and clonal expansion are the basic principle of adaptive 
immunity. The receptor of each lymphocyte recognizes its specific antigen when it 
encounters foreign bacteria and then activates that lymphocyte. These activated cells 
then proliferate and differentiate into the antigen-specific effector cells. After the 
antigen has been eliminated, the response ceases, but the memory cells sustain the 
immunity. Once the pathogen is encountered the second time, the memory cells can 
rapidly proliferate and differentiate into the effector cells to discard the pathogen. The 
responses of the immune system are illustrates in Table 2.3.    
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Table 2.3 The immune responses (Janeway et al., 2005). 
Innate immune response 
(0-4 hr) 
Early induced response 
(4-96 hr) 
Adaptive immune 
response 
(> 96 hr) 
Infection Infection Infection 
Recognition by 
preformed, nonspecific 
effectors 
Recognition of 
microbial-associated 
molecular patterns 
Transport of antigen to 
lymphoid organs 
Removal of infectious 
agent 
Recruitment and activation 
of effector cells 
Recognition by naïve B 
and T cells 
 Removal of infectious agent Colonal expansion and 
differentiation of effector 
cells 
  Removal of infectious 
agent 
 
Cytokines are proteins made by cells that allow cellular communication 
between the innate and adaptive immune responses as well as between the immune 
system and other cells. There are 2 major structural groups of cytokines: the 
hematopoietin family and the tumor necrosis factor (TNF) family. The hematopoietin 
family comprises growth hormomes and interleukins that influence both innate and 
adaptive immunity. Additionally, cytokines from the TNF family also function in both 
innate and adaptive immunity and include many members that are membrane-bound. 
Table 2.4 shows the common cytokines in the body and their functions.  
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Table 2.4. Important cytokines response to bacterial products (Janeway et al., 
2005).  
Cytokine Functions System effects 
IL-1 Activate vascular endothelium 
Activate lymphocytes 
Local tissue destruction 
Increases access of effector cells 
Fever 
Production of IL-6 
IL-6 Lymphocyte activation 
Increased antibody production 
Fever 
Induces acute-phase 
protein production 
TNF-α Activate vascular endothelium and 
increases vascular permeability, which 
leads to increased entry of IgG, 
complement, and cells to tissue and 
increased fluid drainage to lymph nodes 
Fever 
Mobilization of 
metabolites 
Shock 
 
2.2.2 Nutrients and immunity 
Nutrition requirements established by NRC are considered as the minimum 
requirements for maintaining normal growth, health and productivity. NRC (1998) 
also suggested that the “safety-margin” should be added to the suggested amount. 
Meanwhile, the relationship between nutrition and immunity can be complicated. 
Malnutrition or dystrophy is a possible reason for the reduced immune competence of 
weanling pigs and consequently increases the susceptibility to diseases. Either an 
excess or deficiency of energy and/or protein as well as unbalanced vitamins and 
minerals are factors that may cause this result.  
Energy may not directly affect the immune system, but it influences feed 
intake and that determines the intake of other nutrients, such as amino acids, vitamins, 
and minerals. With regard to protein, restricted protein level in the sow diet may 
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reduce the piglet’s survival rate and growth rate as well as the milk yield (DeGeeter et 
al., 1972). However, the protein level (9% vs. 18%) in the sow diet during gestation 
will not influence the antibody synthesis of the piglet and the concentration of IgG, 
IgA, or IgM in the piglet’s serum (Haye et al., 1981). This result suggests that optimal 
restricting of the protein intake of the sow will not affect piglet synthesizing 
antibodies or absorbing immunoglobulin (Kelley and Easter, 1991). NRC (1998) 
suggested that the CP requirement in the gestation sow’s diet is 12 – 13% based on 
corn-soybean meal diet, depending on the sow’s weight at breeding and/or the 
expected litter size.  
Amino acids are important in the proper functioning of the immune system. 
For instance, arginine stimulates not only the secretion of growth hormone and insulin 
that beneficially modulate the immune response, but also the production of nitric 
oxide (NO) that aids macrophages and neutrophils to kill the engulfed microorganism 
(Wu et al., 2004, Kim and Wu, 2009). Furthermore, Johnson et al. (2001) stated that 
glutamine is essential for the normal functioning of macrophages and lymphocytes 
during an immune response. Additionally, Wu et al. (1996) demonstrated that dietary 
glutamine supplementation prevented intestinal atrophy during week 1 post-weaning 
and thus improved the pig’s growth performance consequently.  
Vitamins and minerals function with, or in conjunction with, many enzymes 
and cells that regulate the normal functions of body tissues and aid the immune 
system. Vitamin A, C and E are so called antioxidant vitamins that help protect the 
cell integrity, and thus are beneficial to immunity. Vitamin E has antioxidant 
properties that protect cells from peroxidation. Meanwhile, Se is an integral 
component of glutathione peroxidase and is a complementary role to vitamin E. 
Peplowski et al. (1981) suggested that vitamin E and Se deficiency may retard the 
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production of humoral antibodies. Also, supply of vitamin E and Se in excess of the 
requirement level increase antibody production and lymphocyte proliferation in pigs 
(Larsen and Tollersrud, 1981; Toepfer-Berget al., 2004).  
Vitamin A deficiency influences the integrity of mucosal epithelial cells in the 
respiratory, gastrointestinal, and uterine tracts (Johnson et al., 2001). In addition, 
Vitamin A deficiency decreases lymphocyte proliferation, antigen-specific antibody 
production and T-lymphocyte proliferation in vitro, and increases bacterial adherence 
to respiratory epithelial cells (Chandra, 1993; Friedman and Sklan, 1989). Harmon et 
al. (1963) observed that deficient dietary vitamin A decreases the albumin level in the 
serum and increases α-globulin level and γ-globulin level in weaning pigs. Elevated 
globulin level in the serum may indicate the chronic clinic responses, such as 
pathogen infection, liver disease, or kidney dysfunction (Coons et al., 1955).  
Zn deficiency damages epidermal cells, resulting in skin lesions, which 
represent the loss of the first line of defense of immunity. Zn deficiency also affects 
other mediators of nonspecific immunity, such as polymorphonuclear leukocyte 
function, natural killer cell function, and complement activity. An excess 80 ppm of 
dietary Zn over the requirement improved macrophage function after stimulation by 
phytohemagglutinin (PHA) or pokeweed mitogen (PWM), which suggested that the 
Zn requirement for the immune system in swine is greater than that necessary for 
growth performance (van Heugten et al., 2003b). 
Iron (Fe) is an essential component of hemoglobin which carries oxygen in the 
blood, but it is also an important nutrient for pathogens. Knight et al. (1983) observed 
that excess dose of Fe may stimulate the growth of pathogens and thus affect the pigs’ 
health. Removing Fe from blood to make it inaccessible to pathogens is considered 
part of the host defense (Johnson et al., 2001). Thus, one needs to be aware of the 
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balance between the need for iron for host defense mechanisms and the need for iron 
to sustain microbial growth. Meanwhile, Bala et al. (1992) reported that copper (Cu) 
deficiency reduced T cell responses to mitogen. Similarly, Kornegay et al. (1989) 
showed that high levels of copper seemed to depress the immune response to 
lysozyme and phytohaemagglutinin (PHA) in weaning pigs.  
Additionally, van Heugten and Spears (1997) observed that adding chromium 
(Cr) to diets of weanling pigs improved growth performance and increased 
lymphocyte proliferation after adrenocorticotropic hormone (ACTH) administration. 
This study also showed that supplementation of Cr nicotinate to weanling pigs 
increases antibody production to sheep red blood cells and decrease antibody 
production in response to ovalbumin when measured 14 d following immunization 
(van Heugten and Spears, 1997). However, the effects of applying Cr in the weaning 
pigs’ diet on immune responses are not consistent. van de Ligt et al. (2002) reported 
that Cr supplementation in weaning pig’s diet did not significantly affect growth 
performance and total IgG and IgM concentration in the serum (P > 0.15). 
 
2.2.3 Lipopolysaccharide 
Lipopolysaccharides (LPS), consisting of a lipid and a polysaccharide, are 
found in the outer membrane of gram-negative bacteria and act as endotoxins that 
trigger strong immune responses in animals (van Heugten and Spears, 1997; Webel et 
al., 1997). After encountering microorganisms or their secreted substrate, such as LPS 
or lipoteichoic acid, the leukocytes release cytokines and consequently activate the 
lymphocytes and complement system, which result in triggered different immune 
responses and causes inflammation (Cohen, 2002). This inflammation results in 
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reduced food intake, inactivity, and fever (Johnson and von Borell, 1994; Warren et 
al., 1997).  
The proinflammatory cytokines, e.g., tumor necrosis factor-α (TNF-α) and 
interleukin-6 (IL-6), as well as cortisol, are elevated in plasma in response to 
peripheral LPS injection in weaned pigs. Webel et al. (1997) showed that injecting 5 
μg/kg LPS in weaning pigs causes a 10-fold increase in plasma TNF-α level at 2 hr 
post-injection, 200-fold increase in plasma IL-6 level at 4 hr post-injection, and 
10-fold plasma cortisol level at 4 hr post-injection (Figure 2.2). Moreover, plasma 
urea nitrogen (PUN) also increased 2 to 3-fold at 8 and 12 hr after injection, which 
indicated that skeletal muscle protein may be degraded due to immune responses. 
This research also showed that the responses of injecting 0.5 μg/kg LPS in weaning 
pigs is not as profound as administrating 5 μg/kg LPS.  
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Figure 2.2. The time course of elevated plasma levels of tumor necrosis factor-α 
(TNF-α), interleukin-6 (IL-6), cortisol, and plasma urea nitrogen (PUN) following 
intraperioneal injection of LPS (5 mg/kg BW) (Webel et al., 1997). 
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Overall, pigs with low immunocompetence increase the cost of the 
conventional swine production system. Optimal dietary strategies may improve the 
immunocompetence and thus be beneficial for the pig producer.  
 
2.3 Effects of mannan oligosaccharide supplementation as feed additive 
2.3.1 Function and mechanism 
Most enterobacteria have a specific organelle in the form of type 1 fimbriae 
that mediates the mannose-specific binding to the intestine wall (Firon et al., 1983). 
After adhering to the mucosa surface, the pathogens will then proliferate and colonize 
in the intestine. The attached bacteria can regulate the gene program in intestinal 
epithelial cells and thus influence the expression of epithelial cell products that 
subsequently alter the physiological and biochemical function of the intestinal barrier 
(Kelly, 2004) which suppresses growth performance and immune competence and 
may lead to diseases and diarrhea.  
Mannan oligosaccharides (MOS) are complex sugars that consist mainly of 
mannose that are found mostly in the cell wall of yeast and plants. The main 
components of the cell walls are glycoproteins with minor polysaccharides that 
include cellulose, galactan, and mannan. The polysaccharides that bind to the 
polysaccharide binding domains of the proteins prevent the protein from being 
degraded by the proteolytic enzyme, and then strengthen the cell wall (Flores et al., 
2000). Yeast mannans have a better binding ability to bind E. coli and Salmonella 
than other plant mannans due to their specific carbohydrate linkages (Newman, 2006).  
MOS was first introduced as an animal feed additive in 1993 (Hooge, 2003); it 
is not degraded by digestive enzymes, thus it can pass through the digestive tract 
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(Newman, 1994). Pathogens, which normally adhere to mannans on the mucosal 
surface of the intestine, may instead bind to the mannan component of yeast products, 
thus block the bacterial conjugation (Newman, 2006). And if they do, then the 
pathogens will be flushed from the intestinal tract rather than colonize in the intestine 
(Newman, 1994). Many studies showed that E. coli, which has mannose-specific, 
lectin-like adhesion protein, will not adhere to mammalian cells when mannose is 
presented (Salit and Gotschilich, 1977; Ofek and Beachey, 1978). 
MOS not only suppresses the attachment of the pathogen to the intestinal wall, 
but also eliminates those already colonized in the tract (Newman, 1994). Pluske et al. 
(1997) summarized that pathogens only cause disease when they are colonized and 
infect the epithelial cell of the intestine. Thus, reduced pathogen colonization results 
in a healthy gastrointestinal tract and enhanced digestibility, which consequently leads 
to improved growth performance of the animals. Additionally, the unattached 
pathogen can also be used as attenuated antigens that are presented to immune cells, 
thus triggering the immunoreactions (Kocher, 2004). The following section will 
discuss the effect of feeding MOS on growth performance and immune competence. 
 
2.3.2 Effects of MOS on growth performance 
There are many reports showing the benefit of dietary MOS supplements on 
growth performance of various species. A review paper from Hooge (2006) found that 
adding a MOS product into the milk replacer (4 g per head per day) that is fed to 
calves along with starter feed significantly improved the calf body weight gain by 
15% and starter feed intake by 10% compared to those calves that received no MOS  
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Similarly, MOS also shows effects in other animals. Dietary MOS improved 
the gain and feed conversion when fed to poultry (Parks et al., 2001; Hooge, 2009; 
Sim et al. 2004; Hooge, 2003). Mourão et al. (2006) found that MOS supplementation 
in growing rabbit diets had no effect on growth, but resulted in significantly longer 
villi in the ileum (510 vs. 403 μm, P = 0.002), which suggested that MOS improved 
the gut health of the growing rabbits. Understanding the benefit of MOS in these 
animals helps to explain the potential functions of MOS in pigs. 
In pigs, a recent review paper that evaluated all known MOS results with one 
particular product (Bio-MOS; Alltech Biotechnology Co.) indicated an improvement 
in weight gain and feed conversion ratio when MOS was introduced into the weanling 
pig diet (Miguel et al., 2002). The meta-analysis done by Miguel et al. (2002) showed 
that growth rate, feed intake, and feed efficiency of nursery pigs were significantly 
improved with MOS supplement (4.2%, P < 0.05; 2.1%, P < 0.05; and -2.2 %, P < 
0.05; respectively). The study of LeMieux et al. (2003) showed that MOS improved 
the performance of nursery pigs when the diet included antibiotic and no excess 
dietary Zn. Davis et al. (2002) also found there was a positive effect on nursery 
growth performance from feeding MOS when the diet did not contain excessive levels 
of Cu. 
MOS has been investigated as an alternative to antibiotic supplementation to 
animals. Rozeboom et al. (2005) examined the effect of MOS on growth performance 
of weaning pigs and found that MOS improved the growth rate when compared to the 
control diet that had no antibiotic included (ADG: 394 vs. 368 g, P < 0.05; ADFI: 679 
vs. 661 g, P > 0.05). However, the growth rate of MOS treatment was numerically 
smaller, though not significantly different, than that of the treatment with antibiotics 
(ADG: 394 vs. 406 g; ADFI: 679 vs. 703 g, P value not provided). These results 
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indicated that MOS products have the potential to reduce or replace the use of 
antibiotics. 
 
2.3.3 Effects of MOS on immune responses  
Dietary MOS supplementation affects not only growth performance but also 
the immune systems. Savage et al. (1996) found that concentrations of both blood and 
bile IgG and IgA were significantly increased in turkeys that were fed MOS. In 
broiler breeder diets, the addition of MOS increased the antibody response to 
infectious bursal disease viruses (IBDV) and also increased IBDVl antibody titers in 
the breeders and progeny (P < 0.05; Shashidhara and Devegowda 2003). The addition 
of 10 g MOS/ day to the diet of 40 dairy cows resulted in numerically greater serum 
Ig levels in calves 24-hours after calving than in the calves of unsupplemented cows 
(Franklin et al., 2005).  
MOS has the ability to change the microbial profile and modulate immune 
function in swine. Davis et al. (2004) observed a greater proportion of blood 
lymphocytes and decreased blood neutrophils when pigs were fed MOS. White et al. 
(2002) found that adding MOS to the diet reduced coliform numbers on gut tissue and 
in digesta from the duodenum, jejunum, cecum, and colon (P < 0.05). Similarly, 
MOS-fed pigs had lower enterobacteria population compared with control pigs (P < 
0.05; Castillo et al., 2008). Spring and Privulescu (1998) reported that dietary 
supplemental MOS increased serum IgG concentration from 200 to 916 mg/dL (P 
value not provided) and IgA concentration from 163 to 364 mg/dL (P < 0.05) in 
germ-free pigs. This research also showed that dietary MOS supplement increased 
lymphoblast transformation and macrophage activity, whereas, this effect is more 
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profound in conventional pigs than in germ-free pigs. Pettigrew (2006) observed that 
MOS changes the microbial population in the digestive tract by reducing the diversity 
of the population at 21 days after weaning. Those results imply that MOS 
supplementation has the potential to reduce the outbreak of post-weaning diarrhea by 
lowering the unfavorable microorganisms.  
Castillo et al. (2008) showed that MOS improves gut health by increasing the 
ratio of lactobacilli:enterobacteria (1.57 vs. 0.91; P < 0.05), which is routinely used as 
an indicator of gut health, with an increase in the ratio considered beneficial for gut 
health. The same study also showed that the villus height:crypt depth ratio was higher 
in MOS-fed pigs. Moreover, Mouřao et al. (2006) showed that MOS supplementation 
results in longer villi in the ileum (P = 0.002). Shorter villi and deeper crypt reduce 
absorption but increase secretion, which indicates more substrate for pathogen to 
grow and proliferate. Hence, the results of Castillo et al. (2008) and Mourão et al. 
(2006) suggested that MOS improved the gut health by changing the intestinal 
microflora profile and improving intestinal morphology. 
 
2.3.4. Effects of MOS on sows’ reproductive performance 
It is important to improve the nutrient intake of a sow during late gestation and 
through lactation because sows need enough energy to provide for the growth of the 
fetus. Improving nutrient intake is also necessary for the milk production, the energy 
for recovering from parturition, and the nutrients for piglet growth. There is no direct 
evidence that MOS can increase the nutrient absorption, but there is much indirect 
evidence to show that MOS has the potential to increase growth.  
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The review paper of Pettigrew et al. (2005) concluded from 5 reports that 
adding MOS to a sow’s diet 2-3 weeks before parturition and through the lactation 
period significantly increased the piglets’ average daily gain and subsequent weaning 
weight, but had no effects on sow weight change or litter size. In addition, Maxwell et 
al. (2003) reported that dietary MOS supplementation decreased the number of days 
between weaning and when estrus is exhibited. Medal et al. (2004) showed that 
adding MOS to the sow diet did not affect the pre-weaning mortality; however, 
O’Quinn et al. (2001) and Funderburg (2002) showed that pre-weaning mortality was 
reduced in MOS-fed sows. 
The immune system of a neonate is not fully developed, thus the transferred 
antigen from the sow will be one of the major defenses against pathogens. Several 
reports have shown that colostrum from MOS-treated sows have numerically higher 
concentrations of IgG, IgA, and IgM (Newman and Newman, 2001; O’Quinn et al., 
2001). Similarly, Funderburke (2002) showed that MOS supplementation to sow diet 
improved the colostral IgA (P < 0.10), IgG (P < 0.01), and IgM (P < 0.05) 
concentration.  
The intestine of a newborn animal is considered sterile, however soon after 
birth the intestine is colonized by the gut bacteria from birth canal, teat, sow feces, 
and the environment of the farrowing pen. Therefore, it is important to reduce the 
possibility of the neonates being infected by pathogens. Spring and Geliot (2003) 
observed that adding MOS to the gestation diet 8 weeks prior to farrowing reduced 
the number of coliforms and C. Perfringens in the feces of the sow during farrowing. 
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2.4 Conclusion 
In swine production systems, reproductive performance is a major factor that 
influences profits. Meanwhile, dead pigs, specific facilities for weak pigs, as well as 
injectable antibiotics for ill pigs are extra costs for the pig farm owner. Antibiotics 
have been used in animal feed as growth promoters and to improve health for past 
decades. However, the potential development of antibiotic resistance within bacterial 
populations and residual antibiotics in animal products such as meat and milk has 
grown in the public concern. Thus, it is necessary to find alternative feed additives 
that can also improve growth and efficiency of swine production and to modulate the 
pig’s natural ability to fight diseases. MOS-containing products seem to be one of the 
possible alternatives based on the current literature. 
Therefore, the objective of the studies herein is to more fully evaluate the 
effect of dietary MOS supplementation on the performances of sow reproduction, 
neonatal pig growth and health, and consequently growth and health during the 
nursery period.  
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Chapter 3. Effect of supplying a mannan oligosaccharide (MOS) containing 
product to pig diets on response to an immune challenge 
 
3. 1. Introduction 
Weaning can be a challenge for many young animals because they are 
removed from their mother (psychological stress), perhaps regrouped with new pen 
mates (social and disease stress), and their diet is changed from liquid milk to solid 
feed. These stressful events often occur at a time when their active immunity is not 
yet mature. Many pathogenic bacteria have Type I fimbria that attach to mannose on 
the surface of intestinal cells, which is then followed by colonization and 
development of gastrointestinal disease in the animal (Newman and Spring, 2004).  
Mannan oligosaccharides (MOS) are complex sugars based on mannose. 
Several MOS products have been developed with the view of their potential to modify 
overall intestinal well being. Pathogens which normally adhere to mannans on the 
mucosal surface of the intestine may instead bind to the mannan component of 
products; thus, the pathogens will be flushed from the intestinal tract rather than 
colonize in the intestine. Improving the overall intestinal health by removing potential 
pathogens indicates a greater capacity to cope with potential diseases and may 
ultimately lead to better health and better growth performance (Rozeboom et al., 
2005). The objective of this experiment was to evaluate a modified yeast culture feed 
additive containing MOS on several measures of performance, health, and immune 
response when young pigs were challenged with lipopolysaccharide (LPS) to simulate 
the stress of a disease challenge. 
 
33 
3.2. Experimental procedures 
This experiment was carried out in environmentally controlled rooms at the 
University of Kentucky. The experiment was conducted under protocols approved by 
the Institutional Animal Care and Use Committee of the University of Kentucky. 
3.2.1 Animals and dietary treatments 
A total of 60 crossbred weaned piglets (18-22 days of age) with an average 
initial body weight of 6.0 ± 0.96 kg were assigned to 4 dietary treatments with 3 
pigs/pen (2 barrows and 1 gilt). Treatments were: 1) a control diet fortified to meet 
NRC (1998) nutrient requirements, 2) the control diet with a low level of MOS 
product [0.2% for weeks 1-2 and 0.1% for weeks 3-4], 3) the control diet with a high 
level of MOS product [0.4% for weeks 1-2 and 0.2% for weeks 3-4], and 4) the 
control diet with 0.25% antibiotic [Mecadox® 10; Phibro Animal Health, Ridgefield 
Park, NJ; provided 50 g/ton of carbadox]. An enzymatically hydrolyzed yeast and 
yeast culture product (Cel-Can®; Vi-COR, Mason City IA) containing MOS was the 
product used. There were 8 pens fed Treatment 1 and 4 pens for the other treatments. 
Pigs were provided ad libitum access to feed and water (basal diet compositions are 
provided in Table 3.1). The room temperature was adjusted weekly to maintain it 
within the thermoneutral zone of the piglets.  
 
3.2.2 Experimental diets 
The diets were based primarily on corn, soybean meal, and dried whey which 
were calculated to contain 3,404 kcal/g ME, 21.92 % CP, and 1.38% Lys for Week 1 
and 2; and 3,316 kcal/g ME, 20.80% CP, and 1.21% Lys for Week 3 to 5 (Table 3.1). 
Minerals and vitamins were added to meet or exceed NRC (1998); antioxidants were 
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also included in the diets to elongate shelf life of feeds. The treatment diets were 
made by adding the MOS product to the basal diet by replacing corn. 
 
3.2.3 Lipopolysaccharide challenge 
After 4 wk of growth performance evaluation, 1 barrow and 1 gilt were 
selected from each pen for dietary treatments 1-3 for continuance with assessment of 
immune competence. For the purposes of immune competence assessment, each pig 
received an intraperitoneal injection of 5 mL phosphate buffered saline (PBS) or LPS 
(50 μg/kg body weight) suspended in PBS. The pigs were fasted for a 12 h period 
prior to the LPS and PBS injections to prevent vomiting and for a better estimate of 
feed intake in response to the injections.  
The pigs were injected in the peritoneal cavity 3 nipples down from the caudal 
end almost lateral to the umbilical region on the left side of the pig. Suspended by the 
hind legs, each pig was administered the previously determined injection. Starting at 
0600 h, a pen consisting of 2 pigs was injected every 15 min until the completion of 
all 4 pens within the block. 
The LPS (serotype O111:B4; L-2630; Sigma, St. Louis, MO) was prepared 
using sanitized PBS solution (P-4417; Sigma, St. Louis, MO) to make 0.5 mg/mL 
solution. After the solution was made, it was stored at 4 °C for use the next day. Pigs 
were weighted before injection to determine the volume of LPS solution to deliver 50 
μg/kg body weight in PBS filled up to a final volume of 5mL. The 4 immune 
treatments were: 1) control diet pigs with PBS injection; 2) control diet pigs with LPS 
injection; 3) low level MOS pigs with LPS injection; and 4) high level MOS pigs 
with LPS injection.  
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Table 3.1. Percentage composition of the basal diet (as-fed basis) 
 Week 1-2 (phase 1) Week 3-4 (phase 2) 
Ingredient     % % 
Corn, ground, yellow 49.195 59.855 
Dehulled soybean meal, 48% CP 28.000 28.000 
Dried whey  10.000 8.000 
Spray dried animal plasma 1.500 --- 
Fish meal, menhaden 3.000 2.000 
Lactose   4.000 --- 
Choice white grease  2.000 --- 
DL-Methionine  --- 0.030 
L-Lysine·HCl    0.060 0.020 
Dicalcium phosphate  0.900 0.750 
Limestone, ground  0.750 0.750 
Salt, plain  0.400 0.400 
Trace-mineral mix1  0.075 0.075 
Vitamin mix2  0.100 0.100 
Santoquin3     0.020 0.020 
Calculated nutrient composition  
ME, kcal/g   3,404 3,316 
CP, %   21.62 20.80 
Lysine, %   1.38 1.21 
Calcium, %   0.81 0.71 
Phosphorus, %   0.68 0.62 
1 Provided (per kilogram of final diet): 150 mg Zn (ZnO); 120 mg Fe 
(FeSO4·H2O); 12 mg Cu (CuSO4·5H2O); 45 mg Mn (MnO); 1.5 mg I (CaI2), 0.3 
mg Se (Na2SeO3), 12.375 mg Ca (CaCO3). 
2 Provided (per kilogram of final diet): 6,600 IU of vitamin A, 880 IU of vitamin 
D3, 44 IU of vitamin E, 19.3 mg of vitamin K (as Menadione Sodium Bifulfite 
Complex), 8.8 mg of riboflavin, 22 mg of d-pantothenic acid, 44 mg of niacin, 
33 μg of vitamin B12, 220 μg of d-biotin, and 1320 μg of folic acid.  
3 Supplied 130 mg ethoxyquin per kg of basal diet. 
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3.2.4 Data and sample collection 
During the first 4 weeks of growth, pig weight and feed disappearance from 
each feeder were obtained weekly. For immune competence, body weight, feed 
disappearance, rectal temperature, respiration rate were measured before injection and 
every 2 hr after injection for 12 hr. Body weight and feed intake continued to be 
measured every 24 hr until 1 week post injection. Blood samples were taken before 
injection and at 2, 4, 8, 12, and 24 hr after injection via the jugular vein from pigs 
using a V-trough. The blood samples were then centrifuged at 1390 x g at 4 ºC for 20 
min to obtain serum. These samples were stored at -20 ºC until needed for analysis of 
serum cortisol and tumor necrosis factor (TNF-α; a cytokine that is sometimes 
involved in the fever response).  
 
3.2.5 Laboratory analysis 
The frozen serum samples were thawed at 4 ºC for 2 hours before further 
chemical analysis. The cortisol level in the serum samples were determined by using 
Coat-A-Count Cortisol Kit (Diagnostic Products Corporation, Los Angeles, CA) for 
radioimmunoassay (Appendix I). The TNF-α level in the serum samples were 
determined by using a TNF-α ELISA kit (Pierce Endogen, Rockford, IL) according to 
assay kit instructions (Appendix II). 
 
3.2.6 Statistical analysis 
All data were analyzed as a randomized complete block design with pen as the 
experimental unit and blocks that were based on initial body weight. Analysis of 
variance was performed using the GLM procedure of SAS (SAS Inst. Inc., Cary, NC). 
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Immune growth data were also analyzed using GLM procedure with BW at injection 
as a covariate. Data obtained from the immune response, including rectal temperature, 
respiration rate, and serum cortisol and TNF-α level, was also analyzed by the 
MIXED procedure of SAS to examine time effects. 
 
3.3. Results 
3.3.1. Growth performance 
There was no significant difference (P > 0.10) between MOS treatments and 
control treatment on body weight (BW), average daily gain (ADG), average daily feed 
intake (ADFI), feed:gain ratio during first 4 weeks of the experiment, except feed:gain 
ratio on Week 2 and Phase 1 (weekly performance provided in Table 3.2). In Week 2, 
pigs in the MOS treatments had higher feed:gain ratio compared with those in control 
treatment (1.27 vs. 1.14, P < 0.05); in Phase 1, pigs in the MOS treatments had higher 
feed:gain ratio compared with those in control treatment (1.27 vs. 1.16, P = 0.05). 
The weekly body weight of the pigs that received antibiotic was 3 to 5% 
heavier than that of control pigs. The weekly and overall reports of ADG and ADFI 
were also increased 5 to 7% and 3 to 9%, respectively. These results led to 
approximately 2% reduction of feed:gain ratio.  However, according to the statistic 
analysis, none of these differences were significant (P > 0.14). 
Additionally, compared to the pooled MOS treatments, antibiotic-treated pigs 
had greater BW at week 2 (10.63 vs. 10.03 kg, P < 0.05), but no other difference 
between antibiotic treatment and MOS treatment on ADG, ADFI, and feed:gain ratio 
was detected (P > 0.10).  
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Table 3.2. Effects of dietary MOS supplementation on growth performance of weaned pigs1  
Treatment2 Control 
MOS MOS Anti- 
biotic SEM 
P-values3 
low high MOS effect 
MOS 
Linear 
MOS 
Quad 
Anti 
effect 
Anti vs. 
MOS 
Body weight (kg) 
Week 0 5.99 6.00 5.97 6.01 0.02 0.69 0.38 0.47 0.45 0.29 
Week 1 7.22 7.08 7.16 7.42 0.16 0.55 0.76 0.59 0.32 0.15 
Week 2  10.29 10.00 10.06 10.63 0.22 0.26 0.41 0.52 0.24 0.05 
Week 3 13.48 13.34 13.25 14.27 0.45 0.68 0.67 0.96 0.17 0.10 
Week 4 17.69 17.43 17.79 18.42 0.52 0.88 0.87 0.62 0.27 0.22 
Average daily gain, ADG (g) 
Week 1 175 156 170 201 24.0 0.60 0.85 0.55 0.39 0.21 
Week 2  439 417 414 459 20.1 0.26 0.33 0.69 0.43 0.10 
Week 3 456 477 456 521 40.6 0.80 0.99 0.66 0.21 0.29 
Week 4 601 584 649 592 27.4 0.56 0.17 0.23 0.80 0.48 
Phase 1 307 286 292 330 16.2 0.28 0.45 0.49 0.27 0.06 
Phase 2 528 531 552 557 23.9 0.59 0.42 0.73 0.35 0.61 
Total  418 409 422 443 18.8 0.90 0.85 0.61 0.28 0.24 
Average daily feed intake, ADFI (g) 
Week 1 212 193 221 226 19.1 0.81 0.69 0.31 0.56 0.44 
Week 2  508 529 518 558 26.0 0.55 0.74 0.61 0.14 0.30 
Week 3 926 918 877 970 51.3 0.59 0.45 0.78 0.49 0.27 
Week 4 954 919 1013 965 36.0 0.73 0.20 0.15 0.78 1.00 
Phase 1 360 361 370 392 17.5 0.75 0.64 0.85 0.16 0.24 
Phase 2 940 919 945 968 35.9 0.82 0.90 0.58 0.53 0.42 
Total  650 640 657 680 22.3 0.95 0.78 0.60 0.29 0.27 
Feed/gain ratio 
Week 1 1.24 1.26 1.32 1.15 0.09 0.57 0.46 0.84 0.44 0.22 
Week 2  1.14 1.27 1.26 1.22 0.06 0.04 0.09 0.31 0.25 0.51 
Week 3 2.10 1.97 1.94 1.95 0.14 0.32 0.36 0.77 0.40 0.98 
Week 4 1.59 1.57 1.57 1.63 0.04 0.55 0.60 0.85 0.39 0.19 
Phase 1 1.16 1.26 1.27 1.20 0.05 0.05 0.09 0.42 0.53 0.28 
Phase 2 1.80 1.74 1.72 1.75 0.06 0.21 0.22 0.80 0.49 0.71 
Total  1.57 1.58 1.56 1.55 0.05 0.98 0.88 0.85 0.69 0.71 
1Each means represents 4 pens of 3pigs/pen. 
2Low MOS treatment was the control diet with 0.2 % MOS for Phase 1 and 0.1 % MOS for Phase 
2; High MOS treatment was the control diet with 0.4 % MOS for Phase 1 and 0.2 % MOS for 
Phase 2; Antibiotic treatment was the control diet with 0.25 % antibiotic (as Mecadox) for both 
Phase 1 and Phase 2. 
3P-value of MOS effect was the pooled MOS group compared with the control group; MOS linear 
and quadratic P-value compared the MOS-fed groups and the control group; P-value of antibiotic 
was the antibiotic group compared with the control group; P-value of Anti vs. MOS is the MOS 
groups compared with the antibiotic group. 
39 
3.3.2. Stress responses 
Cumulative growth performance 
Differences were observed among treatments in response to the LPS immune 
challenge. As shown in Table 3.3, Table 3.4 and Figure 3.1, the control pigs 
challenged with LPS lost weight at 2 hr post-injection while PBS-injected pigs gained 
weight (-145 vs. 341 g; P < 0.01). The weight loss of the pigs challenged with LPS 
was not recovered until 12 h post-injection. The LPS-challenged control pigs also had 
lower cumulative feed intake (CFI) compared to PBS-injected pigs (43 vs. 181 g; P = 
0.01; Figure 3.1c). Cumulative weight gain (CWG) or CFI differences were not 
detectable (P > 0.20) at 48 hr post-injection. MOS supplementation of pigs challenged 
with LPS had no effect on CWG or CFI compared to LPS-challenged control pigs. 
The LPS effect was not affected by the initial body weight of the injection (data not 
shown). 
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Table 3.3. Effects of dietary MOS supplementation on body weight (kg) of LPS 
challenged pigs.12 
Injection: PBS3 LPS 
SEM 
P-value 
MOS: 0 0 Low High LPS4 
MOS5 
Low High Pooled 
0h 15.61 17.62 16.80 16.94 0.64 0.08 0.38 0.46 0.36 
2h 15.95 17.47 16.67 16.86 0.65 0.17 0.41 0.52 0.40 
4h 16.22 17.37 16.41 16.80 0.64 0.28 0.31 0.54 0.35 
6h 16.19 17.36 16.37 16.79 0.59 0.24 0.27 0.52 0.31 
8h 16.42 17.46 16.32 16.80 0.60 0.30 0.21 0.46 0.25 
10h 16.48 17.47 16.37 16.84 0.61 0.33 0.24 0.48 0.28 
12h 16.77 17.69 16.49 17.06 0.61 0.36 0.20 0.48 0.25 
24h 16.99 18.14 17.04 17.53 0.61 0.26 0.23 0.49 0.28 
48h 17.91 19.57 18.49 18.93 0.69 0.16 0.30 0.53 0.34 
72h 18.15 20.22 19.38 19.57 0.65 0.08 0.39 0.50 0.38 
96h 19.50 20.88 19.94 20.23 0.65 0.21 0.33 0.49 0.34 
120h 20.11 21.53 20.52 21.02 0.77 0.27 0.37 0.64 0.44 
144h 20.52 22.18 21.09 21.70 0.78 0.21 0.35 0.67 0.43 
1 Each mean represents 4 pens of 2 pigs/pen. 
2 Treatments in this trail were 1) pigs fed control diet with PBS injection; 2) pigs fed 
control diet with LPS injection; 3) pigs fed low MOS (1 %) diet with LPS injection; 
and 4) pigs fed high MOS (2 %) diet with LPS injection.  
3 1 pen in control treatment was removed from the data set because the 2 pigs in this pen 
were injected differently.  
4 Compared PBS group and LPS group without supplemental MOS. 
5 Low MOS compared the low MOS supplemented LPS-challenged pigs and the 
LPS-challenged control group; High MOS compared the high MOS supplemented 
LPS-challenged pigs and the LPS-challenged control group; pooled compared the 
pooled LPS-challenged MOS-fed pigs with LPS-challenged control pigs. 
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Table 3.4. Effects of dietary MOS supplementation on growth performance of LPS 
challenged pigs.12 
Injection: PBS3 LPS 
SEM
P-value 
MOS: 0 0 Low High LPS4 
MOS5 
Low High Pooled 
Cumulative body weight gain, g 
0-2 h 341 -145 -125 -72 69.9 0.002 0.84 0.48 0.60 
0-4 h 617 -245 -388 -131 131.6 0.003 0.46 0.55 0.93 
0-6 h 581 -260 -433 -143 163.5 0.011 0.47 0.62 0.89 
0-8 h 817 -160 -478 -133 180.4 0.009 0.24 0.91 0.53 
0-10 h 876 -148 -425 -100 217.9 0.017 0.39 0.88 0.67 
0-12 h 1,163 70 -305 120 276.2 0.035 0.36 0.90 0.64 
0-24 h 1,388 520 238 590 253.7 0.06 0.45 0.85 0.74 
0-48 h 2,303 1,948 1,695 1,998 190.0 0.26 0.37 0.85 0.67 
0-72 h 2,544 2,603 2,585 2,638 162.4 0.82 0.94 0.88 0.96 
0-96 h 3,896 3,265 3,138 3,290 233.3 0.12 0.70 0.94 0.86 
0-120 h 4,507 3,915 3,718 4,083 288.5 0.22 0.64 0.69 0.96 
0-144 h 4,915 4,558 4,295 4760 330.3 0.50 0.59 0.67 0.94 
Cumulative feed intake, g 
0-2 h 181 43 36 76 27.0 0.011 0.87 0.40 0.68 
0-4 h 306 75 54 101 43.0 0.009 0.73 0.67 0.96 
0-6 h 356 105 54 139 55.9 0.021 0.53 0.67 0.90 
0-8 h 477 168 74 179 64.7 0.016 0.33 0.90 0.61 
0-10 h 563 215 99 226 84.3 0.030 0.35 0.92 0.62 
0-12 h 714 315 171 309 115.2 0.06 0.40 0.97 0.60 
0-24 h 1,162 730 559 696 139.1 0.08 0.40 0.86 0.56 
0-48 h 2,384 1,980 1,671 1,926 187.3 0.20 0.27 0.84 0.45 
0-72 h 3,439 3,243 2,896 3,161 174.4 0.49 0.19 0.75 0.34 
0-96 h 4,943 4,563 4,134 4,486 224.0 0.30 0.21 0.81 0.38 
0-120 h 6,184 5,755 5,394 5,846 244.1 0.29 0.32 0.79 0.66 
0-144 h 7,184 6,860 6,481 7,014 292.7 0.49 0.38 0.72 0.76 
1 Each mean represents 4 pens of 2 pigs/pen.
2 Treatments: 1) control diet with PBS injection; 2) control diet with LPS injection; 3) low MOS 
(1%) diet with LPS injection; and 4) high MOS (2%) diet with LPS injection.  
3 1 pen in control treatment was removed from the data set because the 2 pigs in this pen were 
injected differently.  
4 Compared PBS group and LPS group without supplemental MOS. 
5 Low MOS compared the low MOS supplemented LPS-challenged pigs and the 
LPS-challenged control group; High MOS compared the high MOS supplemented 
LPS-challenged pigs and the LPS-challenged control group; pooled compared the pooled 
LPS-challenged MOS-fed pigs with LPS-challenged control pigs. 
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Figure 3.1. Effects of phosphate buffered saline (PBS) or lipopolysaccharide (LPS) 
challenge on body weight (a), cumulative BW gain (b), and cumulative feed intake 
(c). The volume of LPS solution was determined to deliver 50 μg/kg body weight in 
PBS filled up to 5mL. 
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Table 3.5 Effects of dietary MOS supplementation on respiratory rate and rectal 
temperature of LPS challenged pigs12.  
Injection: PBS3 LPS 
SEM 
P-value 
MOS: 0 0 Low High LPS4 
MOS5 
Low High Pooled 
Respiratory rate, breath/min 
-1h 37.7 34.8 41.4 40.6 2.8 0.52 0.13 0.18 0.11 
1h 50.0 65.0 70.7 65.7 6.0 0.14 0.52 0.93 0.67 
3h 37.9 83.4 67.6 63.8 8.5 <.001 0.04 0.01 0.12 
5h 48.4 64.1 60.9 54.8 4.9 0.07 0.65 0.22 0.33 
7h 37.8 52.6 56.5 50.4 6.3 0.16 0.67 0.80 0.91 
9h 39.9 51.4 48.5 48.9 4.4 0.13 0.65 0.69 0.63 
11h 53.2 45.9 49.3 40.1 3.6 0.22 0.51 0.28 0.79 
25h 37.2 42.3 49.9 40.8 4.8 0.51 0.28 0.83 0.60 
28h 41.4 50
Rectal Temperature,  
.5 43.6 44.0 4.9 0.27 0.35 0.37 0.30 
0h 39.0 39.5 39.3 39.3 0.11 0.03 0.24 0.30 0.20 
2h 39.4 40.2 39.9 39.8 0.11 0.001 0.12 0.04 0.03 
4h 39.5 40.2 39.4 40.0 0.21 0.03 0.04 0.53 0.12 
6h 39.6 39.9 39.6 39.9 0.25 0.22 0.46 0.89 0.70 
8h 39.6 39.5 39.8 39.9 0.12 0.84 0.13 0.04 0.03 
10h 39.6 39.6 39.9 39.6 0.10 0.49 0.08 0.80 0.36 
12h 39.6 39.5 39.8 39.5 0.20 0.94 0.28 0.98 0.54 
24h 39.4 39.3 39.6 39.3 0.10 0.36 0.11 0.81 0.31 
1 Each mean represents 4 pens of 2 pigs/pen. 
2 Treatments: 1) control diet with PBS injection; 2) control diet with LPS injection; 3) 
low MOS (1%) diet with LPS injection; and 4) high MOS (2%) diet with LPS 
injection.  
3 1 pen in control treatment was removed from the data set because the 2 pigs in this pen 
were injected differently.  
4 Compared PBS group and LPS group without supplemental MOS. 
5 Low MOS compared the low MOS supplemented LPS-challenged pigs and the 
LPS-challenged control group; High MOS compared the high MOS supplemented 
LPS-challenged pigs and the LPS-challenged control group; pooled compared the 
pooled LPS-challenged MOS-fed pigs with LPS-challenged control pigs. 
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Respiratory rate and rectal temperature 
With regard to whole-body physiological measures, Table 3.5 and Figure 3.2 
illustrate that respiratory rate of LPS-injected pigs was higher than PBS-injected pigs 
at 3 hr post-injection (83 vs. 38 breaths/min; P < 0.01) and was linearly decreased as 
MOS inclusion was increased in the LPS-injected pigs (83, 68, and 64 breaths/min, 
respectively; P = 0.01). Rectal temperature (Table 3.5 and Figure 3.2) was higher in 
the LPS-injected control pigs than in the PBS-injected pigs at 2 hr (40.2 vs. 39.4 ºC; P 
< 0.01) and at 4 h (40.2 vs. 39.5 ºC; P < 0.05) which is consistent with the 
expectations of this challenge model; MOS-fed pigs had a lower rectal temperature 
than the LPS-controls at 2 hr post-injection (40.2 vs. 39.9 ºC; P < 0.05).  
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Figure 3.2. Effects of phosphate buffered saline (PBS) or lipopolysaccharide (LPS) 
challenge on (a) respiratory rate and (b) rectal temperature. The volume of LPS 
solution was determined to deliver 50 μg/kg body weight in PBS filled up to 5mL. 
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Serum cortisol and TNF-α level 
With regard to serum measures, cortisol levels were higher in the LPS-injected 
control pigs than in the PBS-injected pigs at 2 hr (17.3 vs. 8.6 mcg/dL; P < 0.01) and 
at 4 hr (22.8 vs. 8.9 mcg/dL; P < 0.01) but were not moderated by MOS 
supplementation (Table 3.6 and Figure 3.3). The serum TNF-α responses measured at 
2 hr post-injection (35, 1925, 2069, and 2833 pg/mL for Treatments 1-4, respectively) 
revealed an increase due to the LPS injection (P < 0.05) but no reduction in MOS-fed 
pigs (P > 0.20).  
 
Table 3.6. Effects of dietary MOS supplementation on serum cortisol level and 
serum TNF-α level of LPS challenged pigs.12 
Injection: PBS3 LPS 
SEM 
P-value 
MOS: 0 0 Low High LPS4 
MOS5 
Low High Pooled
Serum cortisol level (μg / dL) 
  0 h 10.5 11.4 10.13 12.1 1.24 0.63 0.48 0.70 0.84 
  2 h 8.6 17.3 17.43 16.3 2.02 0.004 0.96 0.72 0.85 
  4 h 8.9 22.8 22.44 22.8 3.80 < .001 0.90 0.98 0.93 
  8 h 6.9 9.2 13.46 11.7 1.80 0.43 0.13 0.35 0.16 
  12 h 6.4 8.1 8.64 6.8 1.03 0.33 0.70 0.42 0.79 
24 h 8.0 7.4 7.15 7.1 0.61 0.57 0.76 0.74 0.71 
Serum TNF-α level (pg/mL) 
  2 h 34.0 1,162.5 2069.3 2,134.1 597.23 0.24 0.31 0.28 0.23 
1 Each mean represents 4 pens of 2 pigs/pen.
2 Treatments: 1) control diet with PBS injection; 2) control diet with LPS injection; 3) low MOS 
(1%) diet with LPS injection; and 4) high MOS (2%) diet with LPS injection.  
3 1 pen in control treatment was removed from the data set because the 2 pigs in this pen were 
injected differently.  
4 Compared PBS group and LPS group without supplemental MOS. 
5 Low MOS compared the low MOS supplemented LPS-challenged pigs and the 
LPS-challenged control group; High MOS compared the high MOS supplemented 
LPS-challenged pigs and the LPS-challenged control group; pooled compared the pooled 
LPS-challenged MOS-fed pigs with LPS-challenged control pigs. 
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Figure 3.3. Effects of phosphate buffered saline (PBS) or lipopolysaccharide (LPS) 
challenge on (a) serum cortisol level and (b) serum TNF-α level at 2 hr post injection. 
The volume of LPS solution was determined to deliver 50 μg/kg body weight in PBS 
filled up to 5mL.  
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3.4. Discussion 
3.4.1. Growth performance 
MOS has been reported to block the pathogen colonizing on the intestinal wall 
thus changing the microorganism population in the gastrointestinal tract (Newman, 
1994; Spring et al., 2000). Reduced pathogen colonization indicates a healthy 
gastrointestinal tract and enhanced digestibility, which consequently lead to improved 
growth performance of the animals (Pluske et al. 1997). The effect of dietary MOS 
supplementation has been studied on growth performance of various species, such as 
calves (Hooge, 2006), poultry (Park et al., 2001; Sim et al., 2004)), and rabbits 
(Mourão et al., 2006). Most of these studies showed that dietary MOS improved their 
growth rates. However, not all the results are consistent.  
Previous studies have reported that MOS supplementation during the nursery 
period immediately after weaning improves growth rates of piglets. Davis et al. 
(2004) showed that adding 0.3% MOS in the nursery pigs’ diets (including 0.15 g of 
neomycin as neomycin sulfate and 0.11 g of oxytetracline per kilogram of feed) 
improve weight gain and gain:feed ratio in the first 14 d (P = 0.05 and P = 0.01, 
respectively) and overall nursery period (P = 0.03 and P = 0.02, respectively). In 
addition, Davis et al. (2002) found that adding MOS into the nursery pigs’ diet with or 
without CuSO4 improved weight gain (P = 0.04) and gain:feed ratio (P = 0.04) of the 
overall period (d 0-38 post-weaning). A meta-analysis showed that growth rate, feed 
intake, and feed efficiency of nursery pigs were improved with MOS supplementation 
from the product Bio-MOS (4.2%, 2.1% and -2.2 %, respectively; Miguel et al., 
2002). 
However, in the present study, there was no improvement in body weight, 
ADG, and ADFI with supplementation of MOS. Yet, the feed:gain ratio was 
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decreased at 2 wk post-weaning (1.24 vs. 1.14, P = 0,04) and phase 1 (1.24 vs. 1.16, P 
= 0.05). This result is consistent with Castillo et al. (2008). Similarly, LeMieux et al. 
(2003) reported that MOS improved the performance of nursery pigs when the diet 
included antibiotic and no excess dietary Zn after d 7 post-weaning. This report 
suggested that the MOS effect may take at least 1 wk for alternation of the intestinal 
microflora to take place. 
Furthermore, Rozeboom et al. (2005) compared the effect of MOS on growth 
performance of weaning pigs with antibiotic supplementation and found that MOS 
improved the growth rate when the control diet included no antibiotic, though the 
improvement is not as profound as the improvement of adding antibiotic. In the 
present study, there is no difference between the MOS-fed group and antibiotic-fed 
group. However, there is no difference between the antibiotic group and control group 
in this study. This failure to provide a growth response may be related to the 
cleanliness of the research facilities. Previous evaluations of growth responses to a 
variety of dietary amendments have illustrated greater responses when the facilities 
were not as well sanitized (Coffey and Cromwell, 2001; Cromwell, 2001). Thus the 
failure to see a growth response in this study may have been due to using a different 
MOS product or to facilities being too clean. 
 
3.4.2. Immune challenge 
Various reports suggested that MOS enhanced growth performance due to its 
feature of improving gut health as well as immune system (Newman, 1994; Spring et 
al., 2000). Castillo et al. (2008) found that supplying MOS in the nursery diet 
decreased enterobacteria population in the distal jejunum (P < 0.05) at 14 d 
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post-weaning. Similarly, Mourão et al. (2006) observed lower total bacteria count in 
ileal (P < 0.001) and cecal content (P = 0.02) of MOS-fed rabbits at 46 d of age.  
In the present study, LPS injection was utilized to mimic the activation of the 
immune system. Pigs challenged with LPS develop an inflammation, which causes 
reduced food intake, inactivity, and fever. Johnson and von Borell (1994) observed 
that pigs’ feed intake is reduced after injecting 50 μg/kg LPS and is still not recovered 
after 8 hr post injection, which is consistent with the current study. However, MOS 
supplementation on pigs challenged with LPS had no effect on cumulative weight 
gain (CWG) or cumulative feed intake (CFI) compared to LPS-challenged control 
pigs. 
The respiratory rates of LPS-injected pigs are significantly increased at 3 hr 
post injection (P < 0.001) and are not recovered after 7 hr post injection (P > 0.15). In 
addition, rectal temperature is higher in LPS-injected pig than in PBS-injected pigs 
from 0 to 4 hr post injection (P < 0.03) and are recovered at 6 hr post injection (P > 
0.20). This response is similar to that of Wright et al. (2000), who reported that rectal 
temperature of pig injected 100 μg/kg LPS is elevated at 2, 4, 6, 8, and 12 hr after 
administration (P < 0.05). The difference of temperature in LPS-treated pigs and 
control pigs are not detected after 24 hr post injection (Wright et al., 2000).  
Furthermore, Webel et al. (1997) showed that plasma TNF-α and cortisol 
levels after LPS challenge were both increased at 2 and 4 hr, but returned to control 
levels at 8 hr after injection. Wright et al. (2000) reported similar results that plasma 
cortisol was increased in LPS-treated pigs at 2, 4, 6, 8, and 12 hr after LPS injection 
and that plasma TNF-α was raised at 2 and 4 hr after LPS injection  (P < 0.001). 
These results were similar to the current experiment that cortisol levels were higher in 
the LPS-injected control pigs than in the PBS-injected pigs at 2 hr and at 4 hr (P < 
0.01).  
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However, compared to the LPS-challenged control pigs, MOS-supplemented 
pigs had a lower rectal temperature and respiratory rate during the first 4 hr after 
injection, which implied that MOS improves some aspect of the immune function of 
piglets when challenged with LPS. While the rectal temperature and respiratory 
responses are positive, the mechanism of how these reductions were accomplished is 
not yet understood. Certainly it was not by an effect on serum cortisol or TNF-α level 
since there is no difference between MOS-fed or control pigs challenged with LPS. 
Overall, nursery pigs challenged with LPS literally reduced growth rate and 
feed consumption as well as increased body temperature and respiratory rate. They 
also exhibited elevated plasma cortisol and TNF-α concentration. Although MOS had 
no effect on growth performance in this experiment, it provides some benefit for 
weaned pigs during an immune challenge.  
 
3.5. Implication 
The present study indicated that dietary MOS supplementation to weaning pigs 
housed in the sanitation-controlled room may not affect the growth performance 
during nursery period and after challenge with LPS. However, some inflammatory 
responses caused by LPS injection are alleviated in MOS-fed pigs. Further research 
may need to be conducted to evaluate the effect of MOS supplementation on nursery 
pigs’ growth performance and immune responses in the conventional/commercial 
environment. 
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Abstract 
Weaning is a challenge for piglets because they are removed from their mother, 
regrouped with new pen mates, and their diet is changed from liquid milk to solid 
feed. These stressful events also occur at a time when their active immunity is not yet 
mature which may inhibit their response to diseases. The objective of this experiment 
was to evaluate a modified yeast culture feed additive containing MOS, which has 
been suggested to improve immune responses, in pigs challenged with 
lipopolysaccharide (LPS). Weaned pigs were assigned to 4 treatments with 3 pigs per 
pen. The dietary treatments included: 1) control basal diet [n=24], 2) low level MOS 
[0.2% in phase 1 and 0.1% in phase 2 diet; n=12], 3) high level MOS [0.4% in phase 
1 and p.2% in phase 2 diet; n=12], and 4) the control diet with 0.25% antibiotic 
[Mecadox, n=12]. After 4 wk of the growth experiment, 32 pigs (2 pigs per pen from 
Treatment 1 to 3) continued on the diets to examine the response to LPS injection. At 
0600 on d 29, each pig received an injection of phosphate buffered saline (PBS; for 
half of Treatment 1 pigs) or LPS (for all other pigs). At 2 h post-injection, the control 
pigs challenged with LPS lost weight compared with PBS-injected pigs (-145 vs. 341 
g; P < 0.01) and had lower cumulative feed intake (43 vs. 181 g; P = 0.01). 
Cumulative weight gain (CWG) or CFI differences were not detectable at 48 h 
post-injection. MOS supplementation had no effect on CWG or CFI. Respiratory rate 
of LPS-injected control pigs was higher than PBS-injected pigs at 3 h post-injection 
(83 vs. 38 breath/min; P < 0.01) and was linearly decreased as MOS inclusion was 
increased in LPS-injected pigs (83, 68, and 64 breaths/min, respectively; P < 0.01). 
Rectal temperature was higher in the LPS-injected control pigs than in the 
PBS-injected pigs at 2 h (40.2 vs. 39.4 °C; P < 0.01) and at 4 h (40.2 vs. 39.5 °C; P < 
0.01); MOS fed pigs had a lower rectal temperature than the LPS-controls at 2 h 
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post-injection (P = 0.03). Serum cortisol values were higher in the LPS-injected 
control pigs than in the PBS-injected pigs at 2 h (17.3 vs. 8.6 μg/dL; P = 0.03) and at 
4 h (22.8 vs. 8.9 μg/dL; P < 0.01) but were not moderated by MOS supplementation. 
The results showed that LPS challenge affects CWG, CFI, rectal temperature, 
respiratory rate, and cortisol levels and that dietary MOS supplementation reduces 
LPS-induced effects on respiratory rate and rectal temperature, but not on CWG, CFI 
or cortisol levels; thus MOS may provide some benefit for weaned pigs during an 
immune challenge. 
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Chapter 4. Effect of supplying a mannan oligosaccharide (MOS) containing 
product to sow diets on reproductive responses and further effects on nursery 
pigs 
 
4.1. Introduction 
The neonatal intestine is considered as a germ-free environment (Maxwell and 
Stewart, 1995). After the neonates start eating and are exposed to the atmosphere, 
many bacteria will enter the intestine and then colonize. If the major colonization is 
pathogenic bacteria, it may result in the occurrence of diarrhea or other disease. To 
enhance the young animal’s immune resistance, it is important to improve the quality 
and immunoglobulin quantity of milks.  
Mannan oligosaccharide (MOS) is a complex sugar which consists mainly of 
mannose. The mannan functions as ligands for the specific structure, type 1 fimbrial, 
of pathogenic bacteria, such as E. coli, and salmonellae. Once the bacteria 
“recognize” the mannan on the cells in the intestine, they bind to the cell and then 
colonize in the intestine, which subsequently may lead to disease (Newman, 1994). If 
bacteria recognize and bind with the dietary MOS, they may be flushed out of the 
intestine instead of attaching and colonizing the intestinal wall. Dietary MOS 
supplementation has been studied for improving the growth performance and 
immunity of weanling animals (LeMieux et al., 2003; Miguel et al., 2004) and 
reproductive performance of sow (Maxwell et al., 2003; Newman and Newman, 
2001).  
The aim of this experiment was to determine the effect of supplying MOS to 
sow diets on reproductive performance and milk quality and subsequent growth 
performance of piglets fed with or without MOS.  
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4.2. Experimental procedures 
This experiment was carried out in environmentally controlled rooms at the 
University of Kentucky Swine Unit. The experiment was conducted under protocols 
approved by the Institutional Animal Care and Use Committee of the University of 
Kentucky. 
 
4.2.1 Experiment 1 
Animal and treatments 
A total of 28 sows (Yorkshire or Landrace × Yorkshire) with an average parity 
of 1.63 ± 0.92 were assigned to 2 dietary treatments, including 1) control diet that met 
NRC [1998] nutrient requirements and 2) the control diet with  a MOS product 
[0.2% for both gestation and lactation diets]. A modified yeast culture feed additive 
(Celmanax®; Vi-COR, Mason City IA) was the product used in this experiment. 
Celmanax is a unique enzymatically hydrolyzed yeast (EHY) product made of yeast 
culture and hydrolyzed yeast cell wall. It contains yeast culture and other complex 
carbohydrates like D-galactosamine, glucosamine, beta glucans and mannan 
oligosaccharides. 
Sows were allotted to treatment based on parity, breed and breeding weight 
and were housed in individual gestation stalls (0.61 m x 2.13 m) with the rear 0.66 m 
slatted with concrete slats.  Individual floor feeding at a level of 1.8 kg/d was 
maintained throughout gestation and water was available from water nipples on an ad 
libitum basis. The experiment started 14 days before the expected farrowing date, 
approximately day 102 of gestation.  
On approximately d 108 of gestation, sows were moved to a 
temperature-regulated farrowing facility and placed in farrowing stalls (0.61 m x 2.13 
56 
m) with plastic-coated welded wire flooring. Diets were changed to lactation diets and 
were fed on an ad libitum basis until farrowing. Sows were provided 3.2 kg of 
lactation diet on the day of farrowing, and then increased 0.9 kg until the sow started 
leaving feed in the feeder. On the day of weaning, approximately d 19 of lactation, 
sows were returned to the breeding facility for detection of estrous and rebreeding. 
Gestation room temperature and farrowing/lactation room temperature and humidity 
were recorded daily. 
 
Experimental diets    
The diets were based primarily on corn and soybean meal and were calculated 
to contain 3,364 kcal/g ME, 12.62 % CP, and 0.58% Lysine for the gestation diet; 
3,408 kcal/g ME, 17.65% CP, and 1.01% lysine for the lactation diet (Table 4.1). 
Minerals and vitamins were added to meet or exceed NRC (1998). The treatment diets 
were made by adding the MOS product to the basal diet by replacing of corn. 
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Table 4.1. Percentage composition of the basal diet for sows (as-fed basis) 
 Gestation Lactation 
Ingredient % % 
Corn 81.54 67.82 
Soybean meal, 48% CP 12.31 25.15 
Grease 2.00 3.00 
L-Lysine·HCl 0.00 0.10 
Dicalcium phosphate 2.63 2.36 
Limestone 0.69 0.74 
Salt 0.50 0.50 
Mineral mix1 0.08 0.08 
Vitamin mix2 0.05 0.05 
Choline chloride – 60% 0.15 0.15 
Chromax3 0.05 0.05 
Calculated nutrient composition  
ME, kcal/g   3,364 3,408 
CP, %   12.62 17.65 
Lysine, %   0.58 1.01 
Calcium, %   0.89 0.89 
Phosphorus, %   0.80 0.80 
1 Provided (per kilogram of final diet): 160 mg Zn (ZnO); 128 mg Fe (FeSO4·H2O); 12.8 mg 
Cu (CuSO4·5H2O); 48 mg Mn (MnO); 1.6 mg I (CaI2), 0.32 mg Se (Na2SeO3), 13.2 mg 
Ca (CaCO3). 
2 Provided (per kilogram of final diet): 3,300 IU of vitamin A, 440 IU of vitamin D3, 22 
IU of vitamin E, 9.67 mg of vitamin K (as Menadione Sodium Bifulfite Complex), 4.4 
mg of riboflavin, 11 mg of d-pantothenic acid, 22 mg of niacin, 16.5 μg of vitamin B12, 
110 μg of d-biotin, and 660μg of folic acid. 
3 Chromax (Prince Agri Products, Inc., Quincy, IL) provided 200 ppb Cr as chromium 
tripicolinate. 
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Data and sample collection 
Sow feed consumption during lactation was recorded daily. Sows weight were 
obtained on breeding day, pre-feeding (gestation d 101–102), pre-farrowing (gestation 
d 111-113), within 24 h post-farrowing, and at weaning. The number of pigs born 
(alive and dead) and the birth weight of each pig were recorded within 24 h of 
farrowing. In addition, pigs received ear-notches, clipping of needle teeth, and 
injection with 100 mg Fe as Fe dextran on the same day. Some of the piglets were 
transferred to other litters within treatment within 3 days after birth to balance the 
litter size. No transferred piglet died during the experiment. Male piglets were 
castrated at 10-13 days of age. Creep feed was not offered, but access to the sow’s 
feed was not restricted. Individual pig weaning weights were also recorded. 
Blood samples from the sows were collected by jugular venipuncture at 
pre-feeding, pre-farrowing (d111-113 of gestation), early lactation (d 4-6 of lactation) 
and late lactation (d 15-17 of lactation). Colostrum samples were collected within 24 
hr of farrowing. Milk samples were collected to represent early lactation and late 
lactation respectively. Colostrum or milk was hand-expressed from the third and forth 
functional teats of both sides for a total collection of approximately 50 mL. A 1 mL 
oxytocin (20 USP) injection was administered IM in the neck and shoulder area to 
facilitate collection of the colostrum and milk samples. Serum samples from 5 piglets 
in the mid-weight range of each litter were collected by jugular venipuncture using a 
V-trough during early lactation and late lactation. Serum was pooled from those 5 
piglets in the same litter in same ratio (approximately 0.1 mL from each piglet); the 
remaining serum was kept individually as backup. 
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4.2.2 Experiment 2 
Animals, treatments, and diets 
A total of 104 weaned piglets from 7 sows on each treatment in Experiment 1 
were assigned to 2 diets within the litters, including 1) control diet that meet NRC 
[1998] nutrient requirements and 2) the control diet with MOS product [0.2% for both 
Phase 1 and Phase 2 diets]. As each litter was weaned, equal number of barrows and 
gilts were assigned to each nursery diet (extra pigs were not used in the nursery 
experiment). This resulted in a 2 × 2 factorial arrangement with the experimental 
treatments as 1) control sow diet with control nursery diet, 2) control sow diet with 
MOS nursery diet, 3) MOS sow diet with control nursery diet, and 4) MOS sow diet 
with MOS nursery diet. The average weaning weight of all piglets was 6.87 ± 1.04 kg. 
Each treatment was replicated with 7 pens of either 3 or 4 weaning pigs housed in a 
1.2 m × 1.2 m raised wire floor pen equipped with a 4-hole, stainless steel feeder and 
a nipple waterer. Animals were allowed ad libitum access to feed and water. 
The diets were based primarily on corn and soybean meal which were 
calculated to contain 3,404 kcal/g ME, 21.92% CP, and 1.38% lysine for the Phase 1 
diet; 3,316 kcal/g ME, 20.80 % CP, and 1.21% lysine for the Phase 2 diet (Table 4.2). 
Minerals and vitamins were added to the diets to meet or exceed the NRC (1998) 
requirement estimate. No antibiotic was added to the diets.  
 
Data and sample collection 
Body weight and feed disappearance were recorded weekly through the fourth 
week. The experiment included Phase 1 (wk 0-2) and Phase 2 (wk 2–4). Blood 
samples were collected from each pig via the jugular vein using a V-trough on d 14 
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and d 28 post-weaning. The blood samples were then centrifuged at 364 × g at 4 ºC 
for 20 min to obtain serum. Serum samples were stored at – 20 ºC for potential 
immunoglobulin analysis.  
 
Table 4.2. Percentage composition of the basal diet for nursery pigs (as-fed 
basis) 
 D 0 – 14 (Phase 1) D 14 – 28 (Phase 2) 
Ingredient % % 
Corn 49.20 59.86 
Soybean meal, 48% CP 28.00 28.00 
Dried whey 10.00 8.00 
Spray dried plasma protein 1.50 0.00 
Fish meal 3.00 2.00 
Lactose 4.00 0.00 
Grease 2.00 0.00 
L-Lysine·HCl 0.06 0.02 
DL-Methionine 0.00 0.03 
Dicalcium phosphate 0.90 0.75 
Limestone 0.75 0.75 
Salt 0.40 0.40 
Mineral mix1 0.08 0.08 
Vitamin mix2 0.10 0.10 
Santoquin3 0.02 0.02 
Calculated nutrient composition  
ME, kcal/g   3,404 3,316 
CP, %   21.92 20.80 
Lysine, %   1.38 1.21 
Calcium, %   0.81 0.71 
Phosphorus, %   0.68 0.62 
1 Provided (per kilogram of final diet): 160 mg Zn (ZnO); 128 mg Fe (FeSO4·H2O); 12.8 mg 
Cu (CuSO4·5H2O); 48 mg Mn (MnO); 1.6 mg I (CaI2), 0.32 mg Se (Na2SeO3), 13.2 mg 
Ca (CaCO3). 
2 Provided (per kilogram of final diet): 6,600 IU of vitamin A, 880 IU of vitamin D3, 44 IU 
of vitamin E, 19.3 mg of vitamin K (as Menadione Sodium Bifulfite Complex), 8.8 mg of 
riboflavin, 22 mg of d-pantothenic acid, 44 mg of niacin, 33 μg of vitamin B12, 220 μg of 
d-biotin, and 1.32 mg of folic acid. 
3 Supplied 130 mg ethoxyquin per kg of basal diet. 
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4.2.3 Laboratory analysis 
The blood samples were centrifuged at 364 × g at 4 ºC for 20 min after to 
obtain serum. Colostrum and milk samples were centrifuged at 9,950 × g at 4 oC for 
20 and 10 min, respectively, to separate fat from skim milk. After the fat layer was 
removed and discarded, the skimmed colostrum and milk samples were centrifuged at 
39,800 × g at 4 oC for 45 and 20 min, respectively, to separate the whey fraction. 
Serum samples and whey fractions from colostrum and milk samples were stored at 
–20 oC before use for immunological analysis. 
Total IgA, total IgG, and total IgM were measured in all serum and 
colostrum/milk whey samples by enzyme-linked immunosorbent assay (ELISA) test 
(pig IgA/IgG/IgM  ELISA Quantitation Kit, Bethyl Laboratories Inc., Montgomery, 
TX) following the manufacturer's protocol. Detailed analysis procedure is described 
in Appendix III. 
Approximately 10 mL of milk samples were stored as raw milk at – 20 ºC 
before compositional analysis. The raw milk samples were thawed and diluted 4 fold 
with phosphorate buffered saline (PBS) before delivery to the milk laboratory of the 
Division of Regulatory Services, University of Kentucky to analyze milk component. 
The gross energy content of the complete milk was calculated from the concentration 
of protein, fat, and lactose, which contribute 16.4 kJ/g, 38.9 kJ/g, and 23.8 kJ/g 
respectively (Ramanau et al., 2004). 
 
4.2.4 Statistical analysis 
All data were analyzed by ANOVA in a completely randomized design with 
pen as the experimental unit. Analysis of variance was performed using the GLM 
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procedure of SAS (SAS Inst. Inc., Cary, NC). The model used for the sow experiment 
is:  
Y = k + ti + ei;  
In this equation, the parameters represent:  
k = a constant 
ti = the treatment effect 
ei = error term of the model 
In addition, the model for evaluation of the 2 main effect (sow and nursery) 
and interaction is as follows: 
Yij = k + αi + βj + (αβ)ij + eij; 
In this equation, the parameters represent:  
k = a constant 
αi = the sow effect 
βj = the nursery effect 
(αβ)ij = the interaction of sow and nursery effect 
ei = error term of the model 
The sow data were also analyzed using lactation length as covariate; nursery 
data were analyzed using initial BW as covariate. 
 
4.3. Results     
4.3.1 Sow reproductive performances 
The effects of dietary MOS supplementation to sows are shown on Table 4.3. 
The length of gestation and lactation and feed intake during lactation was not affected 
by feeding MOS in the diet, but the sows fed MOS lost weight during lactation while 
sows fed the control diet gained a little (-7.69 vs. 0.54 kg, P < 0.01).  
63 
The litter size did not differ between the MOS group and the control group; the 
litter weight at birth and at weaning for sows fed MOS also did not differ although it 
was more than 10% higher than sows fed the control diet (17.41 vs. 15.21 kg at birth; 
63.75 vs. 55.17 kg at weaning, P > 0.10). When the weight is expressed as individual 
pig weight, then sows fed MOS had heavier piglets than control sows (total born; 1.61 
vs. 1.45 kg, P < 0.10). However, the difference was significant only for the 
born-alive-piglets (1.65 vs. 1.47 kg, P < 0.05). After transferring piglets to balance the 
litter size within treatment, the piglets from sow fed MOS diet were still heavier at 
weaning (6.95 vs. 6.17 kg, P < 0.05). The distribution of individual pig weights is 
provided in Figure 4.1.  
There was no difference between the control and MOS treatments on mortality 
at birth (i.e. percentage of stillborns) (9.85 vs. 9.95, P = 0.98), or at weaning (8.18 vs. 
6.36 %, P = 0.63). Sow weight change during lactation and litter weight at weaning 
may be influenced by the lactation length. Although there is no significant difference 
of lactation length between treatments (18.92 vs. 18.36 d, P > 0.20), using lactation 
length as a covariate was conducted and, predictably, showed similar results (data 
presented in Table 4.4) that MOS treated sows still have heavier live piglets at birth 
(1.65 vs. 1.47 kg, P < 0.05) and at weaning (6.89 vs. 6.33 kg, P < 0.05). 
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 Figure 4.1. Body weight distribution of pigs at various times. 
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Table 4.3. The effect of dietary MOS supplementation on reproductive performance in 
sows 
  Control MOS SEM P-value 
n 11 13 
Average parity 1.82 1.46 
Length, d 
Gestation1 115.55 114.92 0.29 0.14 
Lactation 18.36 18.92 0.50 0.43 
Days to rebreed2 4.33 4.75 0.18 0.12 
Weight change, kg3 
Gestation 32.02 30.52 4.78 0.82 
D 101 - postfarrow 5.66 5.59 1.46 0.97 
Lactation 0.54 -7.69 1.95 0.01 
Lactation feed intake, kg 
Total 95.75 100.91 5.18 0.56 
ADFI 5.21 5.31 0.28 0.80 
Litter size  
Total 10.45 10.92 0.99 0.74 
Alive 9.36 9.85 0.96 0.72 
Post-transfer4 10.00 9.85 0.63 0.86 
Weaning 9.00 9.15 0.48 0.82 
Litter weight, kg 
Total 15.21 17.41 1.47 0.30 
Alive 13.80 16.01 1.41 0.28 
Post-transfer4 15.20 16.08 1.04 0.55 
Weaning 55.17 63.75 3.98 0.14 
Average piglet weight, kg 
Total 1.45 1.61 0.06 0.08 
Alive 1.47 1.65 0.06 0.04 
Post-transfer4 1.52 1.64 0.05 0.13 
Weaning 6.17 6.95 0.24 0.03 
Mortality, % 5 
Birth 9.85 9.95 3.61 0.98 
Lactation 8.18 6.36 2.67 0.63 
1 Gestation length was calculated from the breeding to farrowing date. 
2 Control: n = 9; MOS: n = 12. 
3 Gestation wt. change: wt. difference between breeding and post-farrowing; D 101- postfarrow: 
wt. difference between the date before fed the experimental diet and post-farrowing; Lactation 
wt. change: weight difference between post-farrowing and weaning. 
4No transferred piglet died before weaning. Pigs transferred to Control litters from non- 
experimental sows; pigs transferred within the MOS treatment only from sow in that treatment.
5Birth mortality = [(total litter born- born alive) / total] * 100; Lactation mortality = 
[(post-transferred litter pigs – weaning litter pigs)/post-transferred] * 100. 
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Table 4.4. The effect of dietary MOS supplementation on reproductive 
performance in sows with lactation length used as covariate for selected 
responses. 
Control MOS SEM P-value 
n 11 13 
Lactation length, d1 18.67 18.67 
Days to rebreed2 4.33 4.75 0.18 0.12 
Weight change, kg3 
Lactation1 0.34 -7.51 2.04 0.01 
Lactation feed intake, kg 
Total1 95.75 100.91 5.18 0.56 
ADFI1 5.21 5.31 0.28 0.80 
Litter size 
Weaning 9.00 9.15 0.48 0.82 
Litter weight, kg 
Weaning1 55.52 62.82 3.93 0.20 
Average piglet weight, kg 
Weaning1 6.33 6.89 0.16 0.02 
Mortality4 
Lactation1 8.12 6.38 2.85 0.67 
1 Results are presented as LSMEANS with Lactation Length as covariate. 
2 Control: n = 9; Celmanax: n = 12. 
3 Gestation weight change is the weight difference between breeding and 
post-farrowing; D 101-postfarrow is the weight difference between the day before 
sow was fed the experimental diet and post-farrowing; Lactation weight change is 
the weight difference between post-farrowing and weaning. 
4 Birth mortality = [(total litter born- born alive) / total] * 100; Lactation mortality = 
[(post-transferred litter pigs – weaning litter pigs) / post-transferred pigs] * 100. 
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Table 4.5 The effect of dietary MOS supplementation on sow milk composition 
Control MOS SEM P-value 
Early lactation 
n 10 13 
Fat, % 8.22 8.99 0.55 0.33 
Protein, % 5.56 5.73 0.21 0.58 
Lactose, % 5.84 5.54 0.12 0.01 
Energy, MJ/kg2 5.48 5.77 0.24 0.41 
Late lactation 
n 11 13 
Fat, % 7.67 8.28 0.35 0.22 
Protein, % 4.82 4.92 0.17 0.67 
  Lactose, % 5.90 5.85 0.14 0.79 
Energy, MJ/kg2 5.10 5.35 0.15 0.25 
1Early lactation milk sample was obtained on d 4-6 of lactation; late lactation milk 
sample was obtained on d 15-17 of lactation.  
2Gross energy content of the milk was calculated from the concentrations of protein, 
fat, and lactose. The energy concentrations used were: lactose, 16.4 kJ/g; fat, 38.9 
kJ/g; protein, 23.8 kJ/g (Ramanau et al. 2004).  
 
4.3.2 Sow milk and serum immunoglobulin level during lactation 
Table 4.5 provides the protein, fat, and lactose content of the sow milk. There 
were no differences in these milk components between treatments, but fat and protein 
content were numerically higher in MOS treated sow milk than control sow milk in 
both early lactation (fat: 8.99 vs. 8.22 %; protein: 5.73 vs. 5.56 %, P > 0.20) and late 
lactation (fat: 8.28 vs. 7.67 %; protein: 4.92 vs. 4.82 %, P > 0.20). Lactose content 
was numerically lower at both time points. Because 2 components were numerically 
increased and 1 decreased, there was no difference in the computed energy content. 
Colostrum, milk, and serum immunoglobulin level are presented in Table 4.6. 
MOS treatment increased IgG level 10% in colostrum compared to the control 
treatment, but the result was not significant (57.85 vs. 51.54 mg/mL, P > 0.20). 
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Colostrum IgA and IgM level and both early and late lactation milk IgA, IgG, IgM 
were also numerically higher in MOS treatments, but none of them were significant.  
Sow serum immunoglobulin level had similar results as milk samples. Sows 
with dietary MOS supplementation had numerically higher IgM before farrowing 
(8.55 vs. 6.80 mg/mL, P < 0.20), higher IgA and IgG after farrowing (IgA: 1.33 vs. 
0.68 mg/mL; IgG: 11.08 vs. 5.67 mg/mL, P < 0.20), and higher IgM during late 
lactation (5.21 vs. 3.80, P < 0.05). There was no difference on piglet serum 
immunoglobulin during late lactation between treatments.  
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Table 4.6. The effect of dietary MOS supplementation on milk and serum 
immunoglobulin level, mg/mL1.
Control MOS SEM P-value 
Pre-farrow sow serum 
N 11 12 
IgA 1.18 1.20 0.12 0.91 
IgG 13.80 14.51 1.13 0.65 
IgM 6.80 8.55 0.74 0.11 
Post-farrow sow serum 
N 1 3 
IgA 0.69 1.33 - - 
IgG 5.67 11.08 - - 
IgM 6.83 4.80 - - 
Colostrum 
N 8 7 
IgA 11.22 12.31 1.59 0.63 
IgG 51.54 57.85 5.93 0.46 
IgM 3.70 3.77 0.45 0.91 
Early lactation milk 
N 10 13 
IgA 4.80 5.54 0.53 0.33 
IgG 0.60 0.72 0.12 0.47 
IgM 1.90 2.30 0.25 0.28 
Late lactation milk 
N 11 13 
IgA 3.44 4.10 0.41 0.27 
IgG 0.20 0.26 0.03 0.12 
IgM 1.02 1.26 0.13 0.20 
Late lactation sow serum 
N 10 13 
IgA2 0.88 1.04 0.10 0.29 
IgG 15.84 15.75 0.99 0.95 
IgM 3.80 5.21 0.45 0.04 
Late lactation pooled piglets serum 
n 11 13 
IgA 0.17 0.16 0.04 0.82 
IgG 8.30 7.89 0.77 0.71 
IgM 0.43 0.47 0.04 0.49 
1Pre-farrow serum sample was obtained on the D 111-113 of gestation; Post-farrow serum 
samples and colostrum samples were obtained within 24 h of farrowing; Early lactation 
milk sample was obtained on D 4-6 of lactation; Late lactation milk sample, sow serum 
sample and piglets serum samples were obtained on D 15-17 of lactation.  
2 Control: n = 9; MOS: n = 12 
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Nursery growth performance 
The growth performance during the nursery period of piglets from sows fed 
with or without MOS is presented in Table 4.7. Piglets from sows fed MOS were 
heavier than those from sows fed the control diet at weaning and at each weekly 
weight period of the entire nursery period (P < 0.01). The weekly ADG and ADG of 
each phase of piglets from sow fed MOS were numerically higher than piglets from 
control sows, however, only for the total experimental period was the ADG of piglets 
from MOS treated sows significantly higher than that of piglets from control sows 
(444 vs. 405 g, P < 0.05). 
There was no significant difference in AFDI and feed:gain ratio among sow 
treatments in each week, each phase, nor entire experimental period, but pigs from 
MOS-fed sows had numerical increases in ADFI. The MOS supplementation of 
nursery feeds did not affect growth performance nor was there an interaction between 
sow and nursery feed supplementation.  
The growth performance during the nursery period can be affected by the 
initial BW of pigs in the nursery, thus, Table 4.8 shows the results of growth with 
initial BW as the covariate. The body weight of piglets from MOS treated sows were 
still heavier at Week 1 (8.00 vs. 7.65 kg, P = 0.08). Correspondingly, higher ADG is 
observed at Week 1 (159.03 vs. 109.51 g, P = 0.08). The differences of body weight 
and ADG at the other time period as well as differences of ADFI at any time period 
are not detected when covariate analysis with initial weight is performed. However, 
pigs from MOS treated sows exhibit reduced feed:gain ratio at Week 1 (1.38 vs. 2.55, 
P = 0.10), at Week 3(1.49 vs. 1.61, P = 0.08), and for the entire nursery period (1.53 
vs. 1.61, P = 0.06) after correction with initial BW as covariate.  
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MOS supplementation in starter feed had no effects on BW, ADG, ADFI as 
well as feed:gain ratio with initial BW as covariate. No interaction between MOS 
supplementation in sow diet and in nursery diet is detected. 
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Table 4.7. Effects of dietary MOS supplementation on growth performance of 
weaned pigs.  
Treatments1 
SEM 
P-value 
Sow Control MOS 
Sow Pig S × PPig Control MOS Control MOS 
Body weight, kg 
Week 0 6.49 b  6.52 ab 7.27 a 7.27 a 0.26 0.007 0.93 0.95 
Week 1 7.39 a 7.34 a 8.31 b 8.26 b 0.25 0.001 0.83 1.00 
Week 2  9.95 ab 9.67 b 10.99 a 11.06 a 0.40 0.005 0.79 0.66 
Week 3 13.83 ab  13.15 b 14.86 a 15.12 a 0.46 0.004 0.64 0.32 
Week 4 18.28 ab 17.41 b 19.60 a 19.82 a 0.64 0.007 0.61 0.40 
Average daily gain, ADG, g 2 
Week 1 130 117 149 141 24.3 0.38 0.67 0.91 
Week 2  365 xy 333 y 383 xy 400 x 27.3 0.13 0.78 0.37 
Week 3 555 xy 497 y 554 xy 580 x 31.3 0.20 0.62 0.18 
Week 4 635 609 677 672 33.6 0.13 0.64 0.75 
Phase 1 247 225 266 270 20.2 0.12 0.66 0.50 
Phase 2 595 xy 553 y 615 xy 626 x 28.3 0.11 0.58 0.35 
Total  421 ab 389 b 441 ab 448 a 18.7 0.05 0.51 0.29 
Average daily feed intake, ADFI, g 2 
Week 1 212 201 228 229 18.6 0.24 0.80 0.75 
Week 2  509 511 528 553 30.1 0.31 0.64 0.70 
Week 3 838 798 855 871 37.3 0.24 0.74 0.45 
Week 4 1,054 1,031 1,105 1,117 51.6 0.19 0.91 0.73 
Phase 1 360 356 378 391 21.9 0.24 0.83 0.69 
Phase 2 947 915 980 994 41.4 0.18 0.83 0.58 
Total  653 635 679 693 27.9 0.15 0.93 0.57 
Feed/gain ratio2 
Week 1 1.92 2.33 1.65 1.97 0.46 0.49 0.43 0.92 
Week 2  1.40 y 1.55 x 1.43 xy 1.39 y 0.06 0.32 0.39 0.14 
Week 3 1.52 xy 1.64 x 1.55 x 1.50 y 0.06 0.34 0.58 0.14 
Week 4 1.66 1.70 1.64 1.66 0.03 0.29 0.31 0.81 
Phase 1 1.48 1.60 1.44 1.48 0.07 0.24 0.24 0.51 
Phase 2 1.59 1.67 1.60 1.59 0.04 0.32 0.38 0.22 
Total  1.55 y 1.64 x 1.55 y 1.55 y 0.03 0.17 0.23 0.20 
abc Means with the same letter are not significantly different (P < 0.05). 
xyz Means with the same letter are not significantly different  (P < 0.10). 
1 Pigs form 7 litters of each sow treatments were allotted to 2 nursery treatment diets, 
including the Control diet and the diet with 0.2% MOS, with 3 or 4 pigs per pen and 7 pens 
per treatment. 
2 Phase 1 is Week 1 and Week 2 postweaning; Phase 2 is Week 3 and Week 4 postweaning. 
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Table 4.8. Effects of dietary MOS supplementation on growth performance of 
weaned pigs with initial BW as covariate. 
Treatments1    
SEM 
P-value 
Sow  Control  MOS Sow Pig S x P Pig Control   MOS  Control  MOS 
Body weight, kg    
Week 0 6.89 6.89 6.89 6.89
Week 1 7.69 7.61 8.03 7.97 0.17 0.07 0.67 0.94 
Week 2  10.38 10.06 10.58 10.64 0.30 0.26 0.66 0.51 
Week 3 14.22 xy 13.50 y 14.49 xy 14.74 x 0.41 0.11 0.56 0.23 
Week 4 18.87 17.95 19.04 19.25 0.54 0.23 0.49 0.28 
Average daily gain, ADG, g2   
Week 1 115 104 163 155 23.9 0.07 0.67 0.93 
Week 2 384 350 364 381 26.0 0.85 0.73 0.32 
Week 3 549 xy 491 y 559 xy 586 x 33.1 0.16 0.63 0.19 
Week 4 665 635 649 644 29.8 0.92 0.55 0.68 
Phase 1 250 227 264 268 21.5 0.26 0.66 0.51 
Phase 2 607 563 604 615 29.1 0.45 0.56 0.34 
Total  428 395 434 442 19.4 0.24 0.50 0.28 
Average daily feed intake, ADFI, g 2  
Week 1 205 195 234 236 19.4 0.12 0.81 0.76 
Week 2  529 529 509 534 28.9 0.81 0.65 0.65 
Week 3 848 807 846 862 39.3 0.55 0.74 0.45 
Week 4 1099 1,071 1,063 1,075 45.8 0.75 0.85 0.65 
Phase 1 367 362 372 385 22.9 0.60 0.84 0.68 
Phase 2 974 939 954 968 40.1 0.91 0.78 0.53 
Total  670 651 663 676 27.4 0.76 0.90 0.53 
Feed/gain ratio2    
Week 1 2.36 ab 2.73 a 1.23 b 1.54 b 0.38 0.01 0.35 0.94 
Week 2 1.37 y 1.53 x 1.46 xy 1.42 xy 0.07 0.91 0.36 0.13 
Week 3 1.55 ab 1.67 a 1.52 ab 1.47 b 0.06 0.07 0.58 0.13 
Week 4 1.66 1.69 1.64 1.67 0.03 0.55 0.32 0.80 
Phase 1 1.49 xy 1.62 x 1.42 y 1.46 xy 0.07 0.16 0.25 0.52 
Phase 2 1.60 xy 1.68 x 1.59 y 1.57 y 0.04 0.14 0.38 0.22 
Total 1.57 ab 1.65 a 1.53 b 1.53 b 0.03 0.06 0.23 0.19 
abcMeans with the same letter are not significantly different accroding to LSMEAN with 
covariate as initial weight (P < 0.05). 
xyzMeans with the same letter are not significantly different accroding to LSMEAN with 
covariate as initial weight (P < 0.10). 
1 Pigs form 7 litters of each sow treatments were allotted to 2 nursery treatment diets, 
including the Control diet and the diet with 0.2% MOS, with 3 or 4 pigs per pen and 7 pens 
per treatment. 
2 Phase 1 is Week 1 and Week 2 postweaning; Phase 2 is Week 3 and Week 4 postweaning. 
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4.4. Discussion   
Sow research is traditionally hampered by inadequate numbers of observations 
to detect statistically significant differences between treatments. And, when low sow 
numbers are used, even when a study demonstrates significance in 1 response 
measure, another measure may not be affected statistically even when it is well 
accepted to be biologically related to the one that was affected. While statistical 
significance is necessary to ascribe true treatment effects, evaluation of consistent 
biological movement in responses, of large percentage changes in responses, and of 
patterns of responses reported in the literature may provide inferences relative to how 
to interpret the results. The current study with less than 15 sows per treatment is a 
study with low sow numbers. 
 
MOS effects at lactation 
Feeding during pregnancy is important because it determines the litter size and 
subsequent viability of piglets at birth, the amount of mammary tissue the sow 
contains at parturition as well as the potential milk production of the sow during 
lactation (Pluske et al., 1995). There is no direct evidence that MOS can increase the 
nutrient absorption, but there is much indirect evidence to show that MOS has the 
potential to increase reproductive performances. For instance, Maxwell et al. (2003) 
reported that dietary MOS supplementation may decrease the days back to estrus (6.4 
vs. 5.9 d; P ≥ 0.10); O’Quinn et al. (2001) and Funderburg (2002) showed that 
pre-weaning piglet mortality was reduced in MOS-fed sows. 
In the current study, MOS supplementation in the diet for sows in late 
gestation (14 d prior to farrowing) and throughout lactation has no effect on the 
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number of pigs born alive and weaned as well as preweaning mortality, which is 
consistent with Newman and Newman (2001), O’Quinn et al.(2001), Medal et al. 
(2004), and Maxwell et al. (2003). When dietary treatments are assigned about 2 
weeks before farrowing, there would not be an expected diet effect. Thus equal litter 
size is more of an indication of an appropriate manner of allotment of sows. 
Hall et al. (1987) observed that the survival rate during suckling of pigs that 
weigh less than 0.5 kg was only 7.7% while the survival rate of pigs weighing over 
1.7 kg was over 95%. In the current study, the average piglet weight from MOS-fed 
sow is 1.65 kg and their preweaned mortality is 6.38%, which is close to the number 
that Hall et al. (1987) reported. The piglet weight from the control group is 
significantly lighter than the piglets from MOS group (1.65 vs. 1.47 kg; P = 0.04). 
The survival rate of pig at this weight reported in Hall et al. (1987) is approximately 
85%, which is smaller than the result in the present study. The undetected difference 
of preweaned mortality between MOS group and the control group may be due to the 
clean and low-stress environment.  
In addition, the piglet weight is also improved at weaning (6.95 vs. 6.17; P = 
0.03), which is consistent with Medal et al. (2004), and Maxwell et al. (2003). The 
improved growth performance of piglets during suckling may result from the content 
of the milk. Fat and lactose content supply the energy for the neonatal pigs while 
protein content provides the immune protection and the essential amino acids. In the 
present study, the fat and protein levels in the milk of MOS-fed sows are numerically 
higher than the milk from control sows (P > 0.20). The gross energy content in the 
MOS-fed sow milk (calculated by the equation from Ramanau et al., 2004) is also 
increased 5% compared with the control sow milk (P > 0.25). 
Meanwhile, IgA, IgG, and IgM concentrations in the colostrum are also 
numerically increased. Newman and Newman (2001) reported that colostral IgG and 
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IgM from MOS-fed sows are higher than that in control sows (IgG: 42.15 vs 35.65 
mg/mL, P = 0.16; IgM: 4.40 vs. 3.16, P = 0.04). Similarly, O’Quinn et al. (2001) 
showed that IgG concentrations in colostrum respond significantly to MOS 
supplementation (58.53 vs 48.42 mg/mL, P = 0.007), as well as IgM (2.73 vs. 2.41 
mg/mL, P = 0.03), and IgA (11.78 vs. 10.97 mg/mL, P = 0.06). Furthermore, the 
immunoglobulin concentration is increased at least 15% in the early (d 4-6 of 
lactation) and late (d 15-17 of lactation) milk from MOS-fed sow compared with the 
milk from the control sows, though the differences are not significant (P = 0.12-0.48).  
Increasing nutrient intake during the last 30 days of gestation may aid the fetal 
growth since the fetus grows rapidly during this period (Pluske et al., 1995). In 
addition, it has been determined that the heavier piglet at birth is also heavier at 
weaning (Smith et al., 2007; Tokach et al., 1992,). The reason for having heavier 
piglets at birth from sows with MOS supplementation is not fully understood, but the 
result of heavier piglets at weaning is probably due to the increased weight at birth 
and the potentially improved milk quality.  
 
MOS effects at nursery 
There are many reports showing the benefits of dietary MOS supplements on 
growth performance of weaning pigs. Miguel et al. (2002) reviewed 49 papers and 
concluded that there are improvements in weight gain and feed conversion ratio when 
MOS is introduced into the weanling pig diet. However, there is not much study on 
the effect of MOS supplementation in sow diets their weaned pigs.  
In the present study, weanling pigs from MOS-fed sows were significantly 
heavier at weaning (the beginning of the nursery period) and during the entire nursery 
period (P < 0.01). Though there is no difference in the weekly reports of the pigs’ 
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daily gain between pigs from MOS-fed sows or control sows, the overall, cumulative, 
daily weight gain is improved by MOS supplementation to sow diets (444 vs. 404 g/d, 
P < 0.05). This result is similar to Gracia et al. (2004) who reported that weaned pigs, 
which are coming from sows fed with MOS during their lactation periods, grew more 
than piglets from control sows independently from their dietary treatment after 
weaning (339 vs. 363 g/d, P < 0.05).  
Adding MOS into the nursery diet has no effect on the weaned pigs’ body 
weight and their weight gain. Moreover, the feed intake and feed:gain ratio is not 
affected by MOS supplementation in sow diet or nursery diet. However, Gracia et al. 
(2004) reported that piglets supplemented with MOS tended to have improved feed 
conversion rates than control piglets (1.50 vs. 1.39, P = 0.06). No interactions 
between supplying MOS in sow diet and nursery diet were detected in the current 
study and the study from Gracia et al. (2004). 
Wolter and Ellis (2001) reported that pigs’ weights during nursery and 
growing are affected by their weaning weights. Thus, the results of growth were 
adjusted with initial BW as the covariate. After adjusting the effects by the initial 
weight, the improvement of body weight and weight gain is not profound as before 
correction. However, the difference of feed:gain ratio is improved by sow treatment at 
Week 1 (1.38 vs. 2.55, P = 0.01), Week 3 (1.49 vs. 1.61, P = 0.08) and overall period 
(1.53 vs. 1.61, P = 0.06). This result may indicate that MOS supplementation in sow 
diet affects the growth performance during nursery. MOS supplementation during 
nursery has no effects on growth performance, which is consistent with the previous 
work (Chapter 3). 
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4.5. Implication 
The present study shows that MOS supplementation in sow diet increases the 
piglet weight at birth, at weaning and throughout the nursery period. This result 
suggests that adding MOS to sow diets may increase the profit of the swine producer 
due to the rapid growth rate of the piglets. Meanwhile, the milk composition and 
immunoglobulin concentration from the MOS-fed sow are numerically increased, 
which indicates that the immune system may be improved by MOS supplementation. 
However, further studies need to be conducted to evaluate the mechanism of MOS 
influence on this parameter. 
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Abstract 
The effect of MOS on sow reproductive performance and piglet growth performance 
was evaluated in this study. A total of 28 sows with an average parity of 1.63 ± 0.92 
were assigned to 2 dietary treatments, including 1) control diet and 2) the control diet 
with MOS product. The dietary treatments were started 14 days before the expected 
farrowing date, or approximately day 102 of gestation, and continued throughout the 
lactation period. After weaning, a total of 104  piglets were allotted within litter to a 
2 × 2 factorial arrangement with the experimental treatments as: 1) control sow diet 
with control nursery diet, 2) control sow diet with MOS nursery diet, 3) MOS sow 
diet with control nursery diet, and 4) MOS sow diet with MOS nursery diet. There 
were no significant differences in litter size and litter weight between control sows 
and MOS-fed sows. However, the average piglet weight from MOS treated sows was 
heavier at birth and weaning compared with control sows (1.65 vs. 1.47 kg, P = 0.04 
and 6.95 vs. 6.17 kg, P = 0.03, respectively). The milk composition was also not 
affected by the treatment. Immunoglobulin levels of colostrum and milk were 
numerically greater in sows receiving MOS than control sows (colostrum: IgG 57.9 
vs. 51.5 mg/mL; IgA 12.3 vs. 11.2 mg/mL; IgM 3.8 vs. 3.7 mg/mL; early lactation 
milk: 0.7 vs. 0.6 mg/mL; IgA 5.5 vs. 4.8 mg/mL; IgM 2.3 vs. 1.9 mg/mL; late 
lactation milk: 0.3 vs. 0.2 mg/mL; IgA 4.1 vs. 3.4 mg/mL; IgM 1.3 vs. 1.0 mg/mL) 
but differences were not statistically significant. Piglets from MOS treated sows were 
heavier throughout the nursery period (Wk 0 7.3 vs. 6.5 kg, P = 0.007; Wk 2 11.0 vs. 
9.8 kg, P = 0.005; Wk 4 19.7 vs. 17.8 kg, P = 0.007), but the effect on growth rate and 
feed intake were not significant. MOS supplementation during the nursery period had 
no effect on growth performance. In conclusion, adding the MOS product to sow diets 
80 
during the end of gestation throughout lactation increases both piglet birth and 
weaning weight, as well as the subsequent growth rate during the nursery.  
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Chapter 5. Summary 
 
Antibiotics have been used for improving the animals’ growth performance 
and health (Cromwell, 2001). However, due to health concerns of the consumers on 
animal products and environment concerns, alternative products need to be provided 
to replace the usage of the antibiotics. Mannans oligosaccharide (MOS) has been 
reported to have an effect on enhancing the growth performance and/or 
immunocompetence in various species (Pettigrew, 2000; Parks et al., 2001; Sim et al., 
20004; Mourão et al., 2006; Hooge, 2006). The present study confirms that there are 
benefits from a MOS product (some benefit in a disease challenge as modeled in LPS 
challenge and benefit for sows). However, this study did not demonstrate some of the 
reported benefits that are observed in published literature (e.g., increased growth in 
weanling pigs). 
The mechanism of MOS improving the performances is purportedly from 
blocking the adherence of the microorganisms to the intestinal wall, thus preventing 
pathogens from colonizing and proliferating in the gut (Newman, 1994; Kelly, 2004). 
Pluske et al. (1997) stated that pathogens can only cause disease when they colonize 
and infect the epithelial cells of the intestine. As a result, reduced pathogen 
colonization indicates a healthy gastrointestinal tract and enhanced digestibility, 
which consequently leads to improved growth performance of the animals. Thus, 
improved gut health in sows may indicate that improved nutrient absorption or 
availability may have contributed enhanced reproductive performances in the sows. 
Supplying dietary MOS in weaning pigs improve their growth rate, feed 
intake, and feed conversion rate (Miguel et al., 2002). However, this effect is not 
always consistent. Castillo et al. (2008) also reported that the improvement of growth 
82 
performance was only significant at early phase of nursery, which is consistent with 
the current study (Chapter 3).  
In the current study, LPS was administrated to evaluate the immune responses 
of weaning pig with dietary MOS supplementation. LPS is the endotoxin extracted 
from the outer membrane of gram-negative bacteria which trigger strong immune 
responses in animals, including reduced food intake, inactivity, and fever (Johnson 
and von Borell, 1994; Warren et al., 1997). Dietary MOS supplementation did not 
affect the weight gain, feed intake as well as serum cortisol and TNF-α concentration 
after LPS challenge, compared with control diet-fed, LPS-injected group. However, 
supplemental MOS did alleviate the LPS challenge responses on respiratory rate and 
rectal temperature, which suggested that MOS may provide some benefits for 
weaning pigs during the immune challenge. 
MOS is beneficial not only for the growth performance in weanling pigs, but 
also for the reproduction in sows. In the current study (Chapter 4), MOS 
supplementation in sow diet during late gestation (14 d prior to farrowing) and 
throughout lactation had no effect on the number of pig born alive and weaned as well 
as preweaning mortality. However, the piglet weight is improved at birth and at 
weaning, which are consistent with Medal et al. (2004), and Maxwell et al. (2003). 
The improved growth performance of piglets during suckling period may 
result from the contents of the milk. In the present study, the fat and protein levels as 
well as the gross energy in the milk of MOS-fed sows are numerically higher than the 
milk from control sows (P > 0.20). Additionally, IgA, IgG, and IgM concentrations 
are also numerically higher in the colostrum from sows with supplemental MOS 
compared to control sows. Similar results are observed in Newman and Newman 
(2001) and O’Quinn et al. (2001). Immunoglobulin concentration is also increased in 
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the early (d 4-6 of lactation) and late (d 15-17 of lactation) milk from MOS-fed sow 
compared with the milk from the control sows. Although the differences are not 
significant (P = 0.12-0.48), the 15% improvement may imply that the positive effect 
of MOS supplementation could be verified rather easily if there is a larger sample 
size. 
The subsequent experiment of supplying MOS into the diets of nursery pigs 
(Chapter 4) showed that heavier weaned pigs from MOS-fed sows are significantly 
heavier at the entire nursery period (P < 0.01), so they maintain their weight 
advantage and actually may magnify it. Gracia et al. (2004) reported similar results 
that weaned pigs, which are coming from sows with supplemental MOS in the diet, 
grew faster than piglets from control sows. However, adding MOS into the nursery 
diet in this study again had no effect on the body weight and weight gain. Because 
there were no interactions between supplying MOS in sow diet and nursery diet, there 
does not appear to be any particular benefit, or need, of using the MOS product in 
both diets.  
It has been demonstrated that a heavier pig at birth tends to be heavier at 
weaning (Smith et al., 2007; Hall et al., 1987). Similarly, a high weaning weight 
usually implies rapid and healthy growth after weaning and all the way through to 
slaughter (Wolter and Ellis, 2001; Tokach et al., 1992). Moreover, the preweaning 
survival rate of a heavier piglet is also higher than that of a lighter piglet (Smith et al., 
2007; Hall et al., 1987). These elevated growth performance and survival rate 
observations indicate an increased profit for swine producers with more pigs for 
market, less turnover rate for facilities, less usage of potential medical or nutrient 
supplements cost for treating weaker pigs with heavier birth weights.  
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Pettigrew et al. (2005) calculated the economic effect of feeding Bio-MOS (1 
of the MOS products) to sows. The increased survival rate (2.1%) with 10.2 pigs born 
alive per litter resulted in the extra profit of $6.30 for a litter (assuming a weaned 
piglet has a value of $30). Also, sows that received MOS had fewer days between 
post-weaning and next estrus (1.27 d) in their example, which resulted in an extra 
$0.61 saved (assuming the cost of an unproductive sow is $0.48/d). In addition, the 
increased weaning weight (0.2 kg) with 9.1 pigs weaned/litter contributed extra profit 
of $1.82 for a litter (assuming the additional weight of a pig is worth $1.00/kg). The 
increased growth rate during the nursery period (24 g/d in 32 d of nursery) with 9.1 
pigs weaned/litter contributed extra profit of $6.99 for a litter. However, heavier pigs 
had increased feed intake (31 g/d in a 32-d nursery period) which was an extra cost of 
$1.81 for the feed (assuming the feed price is $0.2/kg) 
Assuming that the cost of a MOS product is $3.50/kg and the MOS intakes in 
gestation (21 d) and in lactation (21 d) are 4 g and 6 g, respectively, then the cost of 
MOS per sow/litter would be $0.74. After adding up these extra profits and costs, the 
MOS effect resulted in an estimated net benefit of approximately $13 per litter.  
10.2 pigs born alive/litter × 2.1% = 0.21 pigs saved/litter 
0.21 pigs/litter × $30/weaned pig = $6.30 extra profit/litter 
1.27 d shorter × $0.48/d of an unproductive sow = $0.61 saved/litter 
0.2 kg/pig × $1.00/kg × 9.1 pigs weaned/litter = $1.82 extra profit/litter 
24 g/pig/d × 32 d × 9.1 pigs weaned/litter × $1.00/kg  
= $6.99 extra profit/litter 
31 g/pig/d × 32 d × 9.1 pigs weaned/litter × $0.20/kg  
= $1.81 extra cost/litter 
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$3.5/kg of MOS × (4 g/d ×21 d gestation + 6g/d ×21 d lactation)  
= $0.74 extra cost/litter 
$ 6.30 + $0.61 + $1.82 + $6.99 - $1.81 – $0.74  
= $13.17 net profit/litter. 
Applying the research results presented in Chapter 4 to the equation developed 
by Pettigrew et al. (2005) showed approximately $19 of net profit per litter when 
MOS was introduced into the sows’ diet.  
9.36 pigs born alive/litter × 1.82% = 0.17 pigs saved/litter 
0.17 pigs/litter × $30/weaned pig = $5.10 extra profit/litter 
0.36 d longer × $0.48/d of an unproductive sow = $0.17 extra cost/litter 
0.78 kg/pig × $1.00/kg × 9.0 pigs weaned/litter  
= $7.02 extra profit/litter 
40 g/pig/d × 28 d × 9.0 pigs weaned/litter × $1.00/kg  
= $10.08 extra profit/litter 
40 g/pig/d × 28 d × 9.0 pigs weaned/litter × $0.20/kg  
= $2.02 extra cost/litter 
$3.5/kg of MOS × (3.6 g/d ×14 d gestation + 12 g/d ×19 d 
lactation) = $0.98 extra cost/litter 
$ 5.10 - $0.17 + $7.02 + $10.08 - $2.02 – $0.98  
= $19.03 net profit/litter. 
Overall, dietary MOS supplementation in the nursery diet may have no effects 
on the weaning pigs’ growth performance (at least with the product evaluated in this 
research), but may have some beneficial influence on pigs under immune challenge. 
In addition, introducing MOS to the sow diet during late gestation and throughout 
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lactation can potentially improve the reproductive characteristics, i.e. litter size, litter 
weight, and mortality, milk composition, as well as the neonatal piglets’ growth 
during suckling and nursery. These improvements imply that MOS supplementation 
may be potentially used as the alternative product for antibiotic and lead to increased 
profits for a swine producer.  
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Appendix I 
Assay to determinate serum cortisol concentration 
The Coat-A-Count Cortisol kit (TKCO1, Diagnostic Products Corporation, 
Los Angeles, CA) was to measure the cortisol content. The shelf life of the cortisol kit 
was 60 days maximum, because the half-life of the 125I was 60 days. The kit should be 
ordered a few days before the use of the kit because of the short shelf life.  
 
Samples and standards:  
The serum samples from individual pigs were measured in duplicate at 
different time points (0, 2, 4, 8, 12, and 24 h post-injection). The kit supplied 1) the 
cortisol Ab-coated tubes, which coated with antibodies to cortisol, 2) 125I cortisol 
solution with blocking agents for steroid-binding protein, and 3) cortisol calibrators 
used as standards. Five standards (1.0, 5.0, 10.0, 20.0, and 50.0 μg/dL) and a blank 
were provided by the kit and measured in triplicate. In addition, label 6 plain 
(uncoated) polypropylene tubes (Fisher-Scientific, Pittsburg, PA) for total counts 
(TC) and non-specific binding (NSB) in triplicates. All components were used at 
room temperature.  
 
Assay procedures:  
1) A 25- μL sample of the 0 calibrator (blank), provided by the kit, was 
pipetted into the bottom of the non-specific binding and blank tubes. All 
standard calibrators supplied by the kit and samples were pipetted in the 
amount of 25 μL into the bottom of their assigned tubes. 
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2) After all standards, blanks, and samples were added to the tubes, 1.0 ml of 
125I cortisol was added to all tubes and the total count tubes within 10 min, 
and then vortex to ensure the solution mixed evenly.  
3) All tubes, except the total count tubes, were incubated in a 37°C water 
bath for 45 min.  
4) Following the water bath incubation, decanted all tubes, except the total 
count tubes, thoroughly by turning the tubes up-side down allowing them 
to drain for 2 or 3 minutes on absorbance cloth to remove residual 
moisture.  
5) The tubes were then read for 1 minute using a gamma counter (Cobra 
Auto-Gamma 5000 series, Gamma Counting Systems with CobraCon Data 
File Conversion Software; Packard Instrument Co., Meriden, CT).  
 
Result calculation:  
To obtain results in terms of concentration of the calibration curve, first 
calculate for the average percentage of binding (%B).  
% B = (count of sample/standard – NSB count) / maximum binding (blank) 
count × 100 
The standard curve was plotted with the %B and the concentration of each 
standard solution in different level. The gamma counter software fitted the standard 
curve using fourparameter logistics and calculated the concentration of the cortisol in 
the samples using the fitted standard curve.  
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Appendix II 
Validation of assay to measure serum TNF-α concentration 
The TNF-α kit (EP2TNFA; Pig TNF-α Colorimetric ELISA Kit; Pierce 
Endogen, Rockford, IL) was used to analyze TNF-α concentrations in the porcine 
serum. The validation of the kit and the validation of the 2 h post-injection time as 
appropriate to measure the serum TNF-α concentration in relation to the LPS injection 
(50 μg/kg BW) was determined using serum sampled from pigs in the preliminary 
experiment and the resulted suggested by Webel et al. (1997). 
 
Samples used:  
The blood samples were collected before and at 2 hr after injection via the 
jugular vein from pigs using a V-trough. The blood samples were then centrifuged at 
1390 x g at 4 ºC for 20 min to obtain serum. These samples were stored at -20 ºC for 
future analysis.  
 
Reagent preparation: 
Sample diluent and wash buffer are prepared the day before the analysis by 
recombining the package of each provided in the kit with nanopure distilled water to 
the volume introduced on the package. The sample diluent is stored in the refrigerator 
while the wash buffer is stored in the room temperature.  
Eight microcentrifuge tubes was labeled 2000, 1000, 500, 250, 125, 62.5, 
31.3, and 0 pg/ml. The standards were prepared on the day of the analysis with 
recombinant porcine TNF-α provided by the kit. Reconstitute lyophilized standard in 
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nanopure, distilled water, and the recombinant TNF-α was brought to volume as 
indicated on the vial. Pipette 200 μL of sample diluent into each prelabeled 
microcentrifuge tube. A 200-μL standard solution, the reconstituted recombinant 
TNF-α was pipetted into the 2000 pg/mL tube. The tube was mixed by gently flushing 
the solution in the pipette tip. A 200-μL sample of the 2000 pg/ml TNF-α solution 
was then pipetted into the 1000 pg/ml tube and mixed gently. The serious dilution by 
transferring the previously prepared solution to the next tube was repeated to create 
all standards. The blank, marked 0 pg/mL, contained only sample diluent.  
The samples were thawed at room temperature on the day of analysis and 
were diluted to 4-fold by adding 50 μL sample to 150 TNF-α sample diluent. No 
sample was thawed and used twice. All standards and blank were measured in 
duplicate while the samples were measured in triplicate. The ELISA plate map was 
determined and labeled prior to analysis (Figure A.2). During the assay, all 
components were used at room temperature.  
 
 1 2 3 4 5 6 7 8 9 10 11 12 
A 2000 
Sample 
0 
Sample 
C
ontrol sam
ples 
Sample 
B 1000 31.3 
C 500 62.5 
D 250 125 
E 125 250 
F 62.5 500 
G 31.3 1000 
H 0 2000 
Figure A2-1. A ELISA plate map used for the analysis of TNF-α. The standards 
occupied column 1 and 5.  
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Assay procedures: 
1) Add 50 μL of sample diluent, provided by the kit, to each well on a plate.  
2) After the sample diluent was added to each well, 50 μL of the standards 
and samples were added to the respective plate wells as marked on the 
map. 
3) The plate was covered and incubated for 2 h at room temperature 
(20-25°C) using an adhesive plate cover strip provided by the kit.  
4) After the 2 h incubation, the plate was washed 3 times using the wash 
solution provided by the kit with the automated wash machine (EL404, 
Micorplate autowasher, BIO-TEK Instruments, Inc., Winoski, VT) and 
then pat onto paper towel to remove residual moisture. 
5) Using a multi-tip pipette, 100 μL of biotinylated antibody reagent 
provided by the kit was pipetted to each well. The plate was then covered 
with an adhesive cover strip and allowed to incubate for 1 h at room 
temperature. 
6) After the incubation period, the plate was again washed 3 times and 
decanted as mentioned previously. 
7) Using the multi-tip pipette, 100 μL of streptavidin-HRP reagent provided 
by the kit was pipetted to each well. The plate was again covered using 
an adhesive cover strip and allowed to incubate for 30 min at room 
temperature. 
8) The plate was again washed 3 times and decanted as mentioned 
previously. 
9) Using the multi-tip pipette, 100 μL of TMB substrate solution provided 
by the kit was pipetted to each well. 
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10) The plate was not covered and placed in a location that it was not in 
direct light and allowed to incubate for 30 min at room temperature.  
11) After incubation, 100 μL of stop solution provided by the kit was pipetted 
to each well using a multi-tip pipette. The plate was not washed or 
decanted after incubation. 
12) The plate was then read on an ELISA plate reader (VERSAmax 
Microplate Reader, MDS Analytical Technologies, Inc., Sunnyvale, CA) 
located in the Agronomy Laboratory, Department of Plant and Soil 
Science, University of Kentucky to measure the absorbance at a 
wavelength of 450nm minus 550nm. The plate were read within 30 min 
after the stop solution was added to the wells. 
 
Calculation of results:  
The plate was read at the wavelength of 450um and 550um. The standard 
curve is generated by plotting the average absorbance (450nm minus 550nm) obtained 
for each of the standards n the vertical (Y) axis vs. the corresponding pig TNF-α 
concentrations on the horizontal (X) axis. The standard curve is showed in Figure 
A2-2. The amount of pig TNF-α in each sample is determined by interpolating from 
the sample absorbance value using the standard curve and multiply to 4 (the dilution 
rate that sample was used). 
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Figure A2-2. A standard curve used to derive the unknown serum TNF-α 
concentration. 
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Appendix III 
Assay to determine the immunoglobulin content in pig milk and serum 
 
The immunoglobulin ELISA kits (pig IgA [E100-102]; IgG [E100-104]; IgM  
[E100-100] ELISA Quantitation Kit, Bethyl Laboratories Inc., Montgomery, TX) is 
quantitatively measuring the immunoglobulin content in biological samples, i.e. 
serum, plasma, milk). The shelf life of the kit is a year stored at 2-8 ºC. The procedure 
and reagent preparation are following the manufacturer's protocol.  
 
Samples used:  
Blood samples from the sows and the piglets were collected by jugular 
venipuncture. The blood samples were centrifuge at 364 × g at 4 ºC for 20 min to 
obtain serum. The serum samples of the piglets used for analysis were pooled from 5 
piglets in the mid-weight range of each litter in same ratio (approximately 0.1 mL 
from each piglet); the remaining serum was kept individually as backup. 
Colostrum or milk was hand-expressed from third and forth functional teat of 
both sides for a total collection of approximately 50 mL. A 1 mL oxytocin (20 USP) 
was administered intramuscular around neck and shoulder area to facilitate collection 
of the colostrums and milk samples. Colostrum and milk samples were centrifuged at 
9,950 × g at 4 oC for 20 and 10 min, respectively, to separate fat from skim milk. 
After the fat layer was removed and discarded, the skimmed colostrum and milk 
samples were centrifuged at 39,800 × g at 4 oC for 45 and 20 min, respectively, to 
separate the whey fraction. Serum samples and whey fractions from colostrum and 
milk samples were stored at –20oC before use for immunological analysis.  
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Reagent preparation: 
Wash buffer, sample diluent, blocking solution, and coating buffer are 
prepared by recombining the package with nanopure distilled water to the volume 
introduced on the package. The stop solution (2M H2SO4) was prepared by diluting 
from high concentrated (95%) sulfate solution. Coating buffer, wash buffer, and stop 
solution are store in room temperature while the blocking solution and sample diluent 
are store at 2-8 oC before analysis. All components were used at room temperature.  
Samples, standards, and HRP conjugate solution were diluted with the sample 
diluents on the day of analysis. The standards were prepared in the concentration of 0, 
15.6, 31.3, 62.5, 125, 250, 500, and 1000 ng/mL for examining IgA and IgM; 0, 7.8, 
15.6, 31.3, 62.5, 125, 250, and 500 ng/mL for examining IgG. The serious diluted 
procedure is similar to the previous description in Appendix II. The HRP solution also 
diluted to 1:75,000 (IgA and IgG) or 1: 50,000 (IgM) suggested by the manufactory’s 
protocol. Capture antibody solution was prepared by adding 0.1 mL antibody solution 
provided in the kit to 9.9 mL coating solution on the day of analysis. The enzyme 
substrate solution was prepared by mixing the 2 substrate solution provided in the kit 
at the same ratio. The enzyme solution need to be fresh prepared before using for 
analysis.  
The samples were thawed at room temperature on the day of analysis and 
were diluted with sample diluent. The dilution rates of the samples were estimated by 
the absorption value of the samples of the preliminary experiment. No sample was 
thawed and used twice. All standards and blank were measured in triplicate while the 
samples were measured in 2 dilutions and triplicate for each dilution. The ELISA 
plate map was determined and labeled prior to analysis (Figure A.3-1). All the 
components and the examination were conducted in the room temperature.  
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 1 2 3 4 5 6 7 8 9 10 11 12 
A 1000 
Sample 
0 
Sample 
1000 
Sample 
B 500 15.6 500 
C 250 31.3 250 
D 125 62.5 125 
E 62.5 125 62.5 
F 31.3 250 31.3 
G 15.6 500 15.6 
H 0 1000 0 
Figure A3-1. A ELISA plate map used for the analysis of immunoglubulins. The 
standards occupied column 1, 5, and 9.  
 
Assay procedures: 
1) Add 100 μL capture antibody solution to each well and incubate for 60 min in 
room temperature. The plate was covered during incubation using an adhesive 
plate cover strip. 
2) After incubation, aspirate the Capture Antibody solution from each well and 
wash 3 times with the automated wash machine (EL404, Micorplate 
autowasher, BIO-TEK Instruments, Inc., Winoski, VT) and then pat onto 
paper towel to remove residual moisture. 
3) Add 200 μL of Blocking (Postcoat) Solution to each well and incubate 30 
minutes. 
4) After incubation, remove the Blocking (Postcoat) Solution and wash each well 
3 times as mentioned above. 
5) Add 100 μL of standard or sample solution to the assigned wells and incubate 
for 60 minutes. After incubation, remove samples and standards and wash 3 
times. 
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6) Add 100 μL HRP Conjugate Diluents to each well and incubate 60 minutes. 
After incubation, remove HRP Conjugate and wash each well 3 times. 
7) Add 100 μL of substrate solution to each well and incubate plate 30 minutes. 
Do not wash the plate after incubation. 
8) To stop the TMB reaction, add 100 μL of 2 M H2SO4 to each well. 
9) Use the microtiter plate reader (VERSAmax Microplate Reader, MDS 
Analytical Technologies, Inc., Sunnyvale, CA), located in the Agronomy 
Laboratory, Department of Plant and Soil Science, University of Kentucky, to 
read the plate at the wavelength of 450nm. The plates were read within 30 min 
after the stop solution was added to the wells. 
 
Calculation of results:  
The example of the standard curve is presented in Figure A3-2. The amount 
of pig immunoglobulin in each sample was determined by interpolating from the 
sample absorbance value using the standard curve and multiply back to the dilution 
rate that sample was used. Each sample was using the equation of the standard curve 
obtained from the same plate.  
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Figure A3-2. An example of the standard curve used to derive the unknown IgM 
concentrations determined by the ELISA. 
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